Next Article in Journal
Investigating the Balance between Structural Conservation and Functional Flexibility in Photosystem I
Previous Article in Journal
The Effect of Orally Administered Multi-Strain Probiotic Formulation (Lactobacillus, Bifidobacterium) on the Phagocytic Activity and Oxidative Metabolism of Peripheral Blood Granulocytes and Monocytes in Lambs
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

The Cellular Response Is Determined by a Combination of Different ELF-EMF Exposure Parameters: A Scope Review

by
Isabel López de Mingo
1,2,
Marco-Xavier Rivera González
1,3 and
Ceferino Maestú Unturbe
1,2,4,*
1
Centro de Tecnología Biomédica (CTB), Universidad Politécnica de Madrid (UPM), 28223 Madrid, Spain
2
Escuela Técnica Superior de Ingenieros de Telecomunicación (ETSIT), Universidad Politécnica de Madrid (UPM), 28040 Madrid, Spain
3
Escuela Técnica Superior de Ingenieros Informáticos (ETSIINF), Universidad Politécnica de Madrid (UPM), 28223 Madrid, Spain
4
Centro de Investigación en Red—Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Madrid, Spain
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2024, 25(10), 5074; https://doi.org/10.3390/ijms25105074
Submission received: 8 April 2024 / Revised: 29 April 2024 / Accepted: 2 May 2024 / Published: 7 May 2024
(This article belongs to the Section Biochemistry)

Abstract

:
Since the establishment of regulations for exposure to extremely low-frequency (0–300) Hz electromagnetic fields, scientific opinion has prioritised the hypothesis that the most important parameter determining cellular behaviour has been intensity, ignoring the other exposure parameters (frequency, time, mode, waveform). This has been reflected in the methodologies of the in vitro articles published and the reviews in which they are included. A scope review was carried out, grouping a total of 79 articles that met the proposed inclusion criteria and studying the effects of the different experiments on viability, proliferation, apoptosis, oxidative stress and the cell cycle. These results have been divided and classified by frequency, intensity, exposure time and exposure mode (continuous/intermittent). The results obtained for each of the processes according to the exposure parameter used are shown graphically to highlight the importance of a good methodology in experimental development and the search for mechanisms of action that explain the experimental results, considering not only the criterion of intensity. The consequence of this is a more than necessary revision of current exposure protection regulations for the general population based on the reductionist criterion of intensity.

1. Introduction

1.1. Introduction Rationale

The study of interactions between magnetic fields and biological systems has been of great scientific interest since the 1980s [1,2,3,4,5,6,7,8,9,10]. From that time until the establishment of exposure guidelines for low-frequency electromagnetic fields (ELF-EMFs), numerous cellular assays were performed that sought significance for alterations found in biological processes [11] such as intracellular calcium flux [1,2,3], mRNA transcription [4,5] or DNA synthesis [6].
Following the establishment of standards for exposure to time-varying electric, magnetic and electromagnetic fields (up to 300 GHz) based primarily on the energy dose received by the cell as a stationary entity [12], there have been numerous reviews published that attempt to compile the number of results that exist in in vitro studies in bioelectromagnetics [13,14,15,16,17,18]. These reviews have traditionally been related to the search for an affirmative or negative answer to the occurrence of certain alterations in cellular processes such as the appearance of tumours [14,19,20,21,22,23,24,25,26,27] or alterations in the immune system [13,28,29,30,31,32,33,34,35] and the reproductive system [36]. With some exceptions, the experimental results have been grouped together without establishing a division by exposure parameters (intensity, frequency, time, waveform, mode) used in the configuration of the exposure system, prioritising the discretisation of the result of the cellular process studied over the exhaustive control of the experimental conditions.
The fact that different combinations of exposure parameters are used makes it difficult to draw conclusions about the effects that these magnetic fields might produce in the different cell models studied [11,21,37,38,39,40,41]; there are many publications that detect non-homogeneity in the choice of parameters as the main reason for the non-replicability of the experiments and that claim that the results are inconclusive and incomparable among the existing publications [11,24,32,42,43,44,45].
This large gap in the literature on in vitro studies in bioelectromagnetics prevents researchers from determining the importance of the different exposure parameters in their experimental developments and, therefore, the search for mechanisms of action that may help to elucidate the results found in their research. Many hypotheses have been put forward [26,46,47,48,49,50,51,52,53,54], but few conclusions have been drawn from the research articles.
Extensively studied cellular processes have been cell viability and proliferation [31,55,56,57,58], apoptosis [16,31,44,59,60], oxidative stress and mitochondria [17,18,36,44,57,58,59,61,62,63], the cell cycle [31,56,59], cell signalling pathways such as the calcium-mediated pathway [15,30,58,64], protein alteration [57,59,63] and genetic effects [23,24,25,31,38,42,43,63], as target cellular processes both to try to apply magnetic field exposures as a possible clinical treatment in different clinical areas [37,50] including wound regeneration [45,65,66], bone repair [67,68,69,70,71], cancer [25] and ischaemic cerebral infarction [72].
This review aims to group articles on in vitro experiments in bioelectromagnetics based on the exposure parameters used (frequency, intensity, exposure time, exposure modality: continuous/intermittent) in the evaluation of the most studied cellular processes (viability, proliferation, apoptosis, oxidative stress and mitochondria, cell cycle), trying to identify differences in cell behaviour based on the parameters used.

1.2. Objective

The objective of this review is to analyse the cellular behavioural response of important cellular processes such as viability, proliferation, apoptosis, oxidative stress/mitochondria and the cell cycle when different cell lines are exposed to a magnetic field identifying the importance in the choice of exposure parameters (the frequency, intensity, time and continuous/intermittent mode of exposure). A bibliographic search was carried out in the NCBI PubMed and Scopus databases in which articles were identified that met a series of previously defined characteristics in order to narrow down the selection of items and to adjust the review to the main objective of the discussion, the importance of exposure parameters in the behavioural response of cells. The objectives of the review, inclusion/exclusion criteria and study design were defined by the PECOS guidelines (Population, Exposure, Comparison, Outcome, Study design). The PECOS statement was “What is the association between magnetic field exposure parameters and cellular response?”. As a consequence, the different sections of the PECO are as follows: in vitro models of immortalised or primary human or mouse/rat tumour and non-tumour cells (P); exposure to magnetic fields with frequencies (0–300] Hz with a continuous or intermittent exposure mode, intensities less than 1 T and any exposure time and waveform (E); sham-exposed (sham) control sample (P); alterations in viability, apoptosis, proliferation, oxidative stress levels and the cell cycle considering all the biomarkers (O) of molecular biology assays specific to the processes described above and original research in comparison with controls (no exposure) (S).

2. Methods

The scope review follows the PRISMA-ScR guidelines (Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews) [73]. The methodology of this scoping review is registered in the Open Science Framework repository (https://osf.io/yp295) on 10 April 2024. The checklist is included in the Supplementary Material (Document S1).

2.1. Eligibility Criteria

The selected articles had to be published in peer-reviewed scientific journals and be original research, so conference proceedings, reviews and book chapters were not included. The articles had to be written in English and be published in Open Access or be accessible through agreements between the scientific institution and the publisher.
We searched for studies performed on cell cultures in any cell line, without discarding articles for being immortalised lines/primary cell cultures, tumour/non-tumour, adherent/in suspension, human/animal cells or restricting the search to a specific tissue of origin. Only monolayer results have been considered in the articles studying 3D cultures or conventional monolayer cultures. The cell parameters chosen were viability, proliferation, apoptosis, oxidative stress and mitochondria injury and the cell cycle regardless of the biomarker used. Articles that did not study these cell parameters were discarded, e.g., genetic studies.
The exposure restrictions were magnetic field, with frequencies (0–300] Hz and intensities regardless of magnitude. No discrimination was made according to the exposure system used, neither by exposure time nor by continuous/intermittent mode. Original research articles that met all cellular requirements but did not show complete technical information related to magnetic field exposure (e.g., did not include frequency, intensity, exposure time, etc.) were discarded.
All articles comparing two distinct populations, one exposed to magnetic fields and one not exposed to the magnetic field (control) shielded or not by high permeability material (e.g., mu metal chamber), were included.

2.2. Information Sources and Search Strategy

The databases reviewed were NCBI PubMed and Scopus. Articles were selected from the year 2000 to 2023. The searches were performed on 4–6 November 2023. Both databases were queried as follows: “ELF-EMF AND cell”. In the case of NCBI PubMed, a total of 251 results were returned, 332 in the case of Scopus.

2.3. Selection of Sources of Evidence

All articles were selected based on the title and the abstract describing them. Those that did not meet the requirements established in the PECOS statement were excluded. They were selected independently between databases and then proceeded to the elimination of duplicates. The selected articles were imported in their complete version into the reference management software Mendeley® (Mendeley Reference Manager, v. 2.110.0, Elsevier, London, UK). Once analysed in depth, we excluded those that did not fully meet the inclusion requirements. For all excluded items, the reason for exclusion is indicated (see Supplementary Material, Table S1). The results of this filtering process can be seen in the PRISMA flow chart (Figure 1).

2.4. Data Charting Process and Data Items

Each of the selected articles has been carefully read, and the following information has been extracted in a summary table that has served as the basis for writing each of the sections of this review:
  • Author and year of publication (full reference of the selected article);
  • Cell line used;
  • Frequency;
  • Intensity;
  • Exposure time;
  • Exposure mode (intermittent/continuous);
  • Results obtained: significant or non-significant for each cellular process studied (viability, proliferation, apoptosis, oxidative stress/mitochondria, cell cycle).

2.5. Synthesis of Results

Different divisions have been performed for the synthesis and analysis of the results:
  • First division: continuous (C)/intermittent (I) exposure. The articles were separated according to whether the exposure was continuous over time or intermittent (ON/OFF) regardless of the exposure time.
  • Second division: tumour cells (T)/non-tumour cells (NT). The results of the different articles are divided according to whether they use tumour or non-tumour cells independently of the tissue from which they originate.
  • Third division: frequency. Two frequency divisions are established: exposures at frequencies less than or equal to 50 Hz and exposures greater than 50 Hz.
  • Fourth division: intensity. Four levels of intensity are established: exposures at intensities less than or equal to 100 µT, exposures greater than 100 µT and less than or equal to 1 mT, exposures greater than 1 mT and less than or equal to 5 mT and, finally, exposures greater than 5 mT.
  • Fifth division: time. Three exposure time bands are established: exposures less than or equal to 1 h; exposures greater than 1 h and less than or equal to 1 day; and, finally, exposures greater than 1 day.
The results are categorised as follows: non-significant (0), statistically significant decrease (1), statistically significant increase (2).

3. Results

3.1. Selection of Sources of Evidence

The results of the bibliographic search can be seen in Figure 2A, which shows the diagram of the identification of databases and records using the PRISMA-ScR protocol. As previously established, the PubMed and Scopus databases were used for item selection. A total of 583 articles were identified (PubMed n = 251; Scopus n = 332); of these, 222 duplicates, 23 that were not in English or not available for reading and 93 that were not performed in in vitro models were eliminated. A total of 245 articles were obtained, of which 150 were excluded for not meeting the requirements imposed: review/opinion article/book chapter (41), not measuring the selected cell parameters of viability, proliferation, apoptosis, oxidative stress, cell cycle (56), RF or static field (3), prior to the year 2000 (13), electric field (1) and in models other than in vitro (36). After these exclusions, the number of articles was reduced to 95. In the last screening step, 5 review/opinion article/book chapters and 11 articles that meet the cellular processes to be reported were excluded. The total number of items included in this review is 79. Figure 2B shows the articles finally excluded and included in this review according to the criteria imposed and the articles excluded according to the exclusion criterion (duplicate articles are not represented). As can be seen, the main reason for exclusion is not being performed on an in vitro model (45.74%) followed by not complying with the cellular processes to be studied (23.75%).
All articles considered in the database with exclusion criteria can be found in the Supplementary Material.

3.2. Characteristics of Sources of Evidence

Figure 3 shows the temporal distribution by the year of publication of the articles included in this review. Most of these articles were published in 2014–2015. An increase in valid articles is observed from 2012 onwards, with minimal articles included before 2010.
The different experiments carried out in the articles selected for the review were extracted, a total of 531 (Figure 4A). These experiments were divided according to specific exposure parameters: frequency, intensity, exposure time and exposure mode (continuous vs. intermittent). For each of them, the impact of the parameter on certain cellular processes was determined: viability (continuous: Table 1; intermittent: Table 2), proliferation (continuous: Table 3; intermittent: Table 2), apoptosis (continuous: Table 4; intermittent: Table 2), oxidative stress/mitochondria (continuous: Table 5; intermittent: Table 2) and cell cycle (continuous: Table 6; intermittent: Table 2). A further division was made according to experiments carried out on tumour vs. non-tumour cells.
Most of the experiments collected show results for viability processes (49.72%) followed by proliferation processes (15.82%), apoptosis (12.62%) and oxidative stress/mitochondria (12.05%) (Figure 4A). The process with the least results is the cell cycle (9.79%). Most of the experiments were performed on tumour cells (56.12%), with the cellular processes of apoptosis (T: 51; NT: 16) and the cell cycle (T: 18; NT: 34) showing the greatest decompensation in the use of tumour or non-tumour cells (Figure 4B).

3.3. The Results and Critical Appraisal of the Source of Evidence

Figure 5 shows the distribution of the experiment results over 100% of the set of experiments for a specific cellular process. The majority of the in vitro studies of magnetic field exposure (0–100] Hz using tumoral cells find a decrease in viability (30.30%), with a minimal proportion of articles finding an increase in viability (2.65%) (Figure 5A). In the case of non-tumour cells, most results show an increase in cell viability (23.86%), with the percentage of results showing a decrease in this process being almost nil (0.38%) (Figure 5A). In the case of the analysis of proliferation, when tumour cells are exposed to magnetic fields, most show a decrease in proliferation (25.00%), while in non-tumour cells, the percentage showing a decrease is lower (8.33%) than that showing an increase (14.29%) (Figure 5B). In the case of apoptosis, the same number of experiments with tumour cells show an increase (7.04%) as a decrease (7.04%) (Figure 5C). The apoptosis results in non-tumour cells show only increased apoptosis, although the percentage over the total is small (9.86%) (Figure 5C). The large percentage of non-significant results in the assessment of apoptosis in non-tumour cells (63.38%) is remarkable. The oxidative stress results in tumour cells show a higher proportion of cells responding with increased (32.81%) versus decreased oxidative stress (4.69%), which coincides with the proportion of non-tumour cells responding with increased (25.00%) versus decreased (4.69%) (Figure 5D). Finally, in the case of the cell cycle, the percentages of results showing statistically significant results in tumour cells (15.38%) and non-tumour cells (15.38%) are similar in proportion over the total (Figure 5E).
As shown in Figure 6, most experiments were performed in a frequency range of (0–50] Hz (80.04%), at intensities between (0.1–1] mT (31.83%) and (1–5] mT (32.2%), an exposure time between 1 and 24 h (44.63%) and in continuous exposure mode (85.23%).

3.3.1. Frequency

Figure 7 shows the viability results obtained in the first division of a frequency range of (0–50] Hz and (50–100] Hz (Figure 7A,B).
Viability processes in tumour cells are studied in a higher proportion in frequency ranges up to 50 Hz (73.65%) (Figure 7A). They generally show a decrease in cell viability in both frequency groups (up to 50 Hz: 42.57%; above 50 Hz: 14.66%), and only 4.73% of studies in tumour cells show an increase in viability in the (0–50] Hz range (Figure 7A). In the case of non-tumour cells, the generalised response is an increase in viability for both frequency bands (Figure 7B). Again, the most studied frequencies are in the (0–50] Hz range (Figure 7B). No data of decreased viability are shown for this cell group (Figure 7B).
A second frequency division is established for the viability assays in the 20 Hz range from 0 to 100 Hz. Most studies are concentrated in the frequency range (40–60] Hz, and this frequency has the highest percentage of negative results (25.68%) (Figure 7C). In the case of non-tumour cells, the same frequency range is the most studied, also being the one that returns the highest viability values (38.79%) (Figure 7D).
In the case of proliferation, lower frequencies (0–50] Hz produce a greater decrease in the proliferative capacity of tumour cells (47.73%) compared to non-tumour cells that show a tendency to increase this capacity (30.00%) (Figure 8A,B). There are no results for tumour cells for frequencies higher than 50 Hz among the chosen experiments, but there are results for non-tumour cells with mostly non-significant results (17.50%).
The apoptosis assays show a very significant increase in non-significant results for the range of frequencies studied, both in the case of tumour cells and non-tumour cells (Figure 8C,D).
In the oxidative stress results, a considerable increase is observed in tumour cells in both frequency groups (up to 50 Hz: 40.54%; above 50 Hz: 16.22%) (Figure 8E). In non-tumour cells, there is an increase in oxidative stress at frequencies below 50 Hz (55.56%) (Figure 8F). At higher frequencies, we found a greater number of decreasing results (7.41), as opposed to increasing (3.70%) (Figure 8F).
Regarding the cell cycle, tumour cells show effects occurring at low frequencies (0–50] Hz (44.44%), with no effects at frequencies higher than 50 Hz (Figure 8G). In non-tumour cells, a higher percentage of effects is found at low frequencies (0–50] Hz (17.65%) with a lower percentage at frequencies higher than 50 Hz (5.88%) (Figure 8H). However, most results in non-tumour cells for both frequency ranges are non-significant (frequencies below 50 Hz: 26.47%; frequencies above 50 Hz: 50%) (Figure 8H).

3.3.2. Intensity

Figure 9 shows the results in viability (Figure 9A,B), proliferation (Figure 9C,D), apoptosis (Figure 9E,F), oxidative stress (Figure 9G,H) and cell cycle processes (Figure 9I,J) obtained according to intensity bands: (0–0.1] mT, (0.1–1] mT, (1–5] mT and higher than 5 mT.
The viability results show that in the case of tumour cells, high intensities show the highest percentage of decrease, (1–5] mT (31.08%) and higher than 5 mT (16.89%) (Figure 9A). In the case of non-tumour cells, viability increase results are shown in the range of (1–5] mT (42.24%), being the percentages similar in results that have no significant effect (6.90%) to those that obtain an increase in viability (7.76%) at intensities higher than 5 mT (Figure 9B).
In the case of proliferation, tumour cells show increased results of a decreased proliferative capacity at intensities of (0.1–1] mT (34.09%) (Figure 9C). At lower intensities (0–0.1] mT, the results between increase (11.36%) and decrease (9.09%) are very similar (Figure 9C). In the case of non-tumour cells, significant results of an increased proliferative capacity are found at intensities of (0.1–1] mT (30.00%), although there is a high percentage of results showing non-significant results (37.50%) (Figure 9D). Also, in the same range of intensities, there is a decrease in this capacity, although in a much lower percentage (10.00%) (Figure 9D). The rest of the intensities show no significant results (Figure 9D).
In the apoptosis process, tumour and non-tumour cells show mostly non-significant results (Figure 9E,F). In non-tumour cells, an increase in cell death is shown at intensities of (0.1–1] mT (25.00%), but for all other intensities, the non-significant results are greater than the increase or decrease effects (Figure 9F).
Oxidative stress is increased in tumour cells in intensity ranges of (0–0.1] mT (13.51%), (0.1–1] mT (21.62%) and intensities higher than 5 mT (18.92%) (Figure 9G). In this case, non-tumour cells respond similarly in the same intensity ranges, except at intensities higher than 5 mT where the majority of the effects are decreasing (7.41%) (Figure 9H).
The cell cycle shows the highest number of effects at intensities of (0.1–1] mT in tumour (33.33%) and non-tumour (11.76%) cells (Figure 9I). However, a very high number of non-significant results are found for each of the intensity ranges (Figure 9J).

3.3.3. Exposure Time

Figure 10A shows the results in viability (Figure 10A,B), proliferation (Figure 10C,D), apoptosis (Figure 10E,F), oxidative stress (Figure 10G,H) and cell cycle processes obtained according to exposure time bands: (0–1] h, (1–24] and more than 24 h.
Tumour cells show a similar trend in all the time slots collected, although there is a small increase in viability at exposure times longer than 24 h (4.73%) that does not appear at all other times (Figure 10A). In the case of non-tumour cells, the proportion of significant results decreases with increasing exposure time, (0–1] h (0: 3.45%; 1: 17.24%), (1–24] h (0: 21.55%; 1: 33.62%) and times longer than 24 h (0: 19.83%, 1: 3.45%) (Figure 10B).
In proliferation, tumour cells show a tendency to decrease in proliferative capacity as exposure time increases, (1–24] h (6.82%), times greater than 24 h (38.64%) (Figure 10C). In non-tumour cells, the trend is towards increased proliferation in all three time bands, although decreasing results begin to appear in cells exposed at times greater than 24 h (17.50%) (Figure 10D).
In the case of apoptosis, no differences are shown in tumour cells for any of the time bands studied (Figure 10E). In non-tumour cells, the proportion of increased apoptosis responses and non-significant results is very similar in the time bands where data are shown, (1–24] h (0: 43.75%; 2: 25.00%), times greater than 24 h (0: 12.50%; 2: 18.75%) (Figure 10F).
Oxidative stress processes show a proportional increase with exposure time in tumour cells, (0–1] h (8.11%), (1–24] h (16.22%) and times longer than 24 h (32.43%) (Figure 10G). In the case of non-tumour cells, the highest proportion of the results clustered around exposure times of (0–1] h (18.52%) and (1–24] h (33.33%), although in this case, this does not appear to be related to time course (Figure 10H).
Finally, the cell cycle results show an increase in effects with increasing exposure time in tumour cells (1–24] h (5.56%), times longer than 24 h (38.89%) (Figure 10I). In the case of non-tumour cells, there is no increase in the results as exposure time increases, and the proportion of non-significant results and the appearance of effects is proportional between the time slots studied (Figure 10J).

3.3.4. Exposure Mode

Figure 11 shows the results in viability (Figure 11A), proliferation (Figure 11B), apoptosis (Figure 11C), oxidative stress (Figure 11D) and cell cycle (Figure 11E) processes obtained according to exposure mode, continuous (C) or intermittent (I).
In the case of viability assays, both continuous and intermittent modes of exposure show similar results, with intermittent exposure showing a slightly higher percentage of studies returning a decrease in viability (C: 30.68%; I: 38.10%) (Figure 11A). The proliferation results show an increase in the proliferative capacity of cells exposed to an intermittent mode of exposure (41.18%), compared to a continuous mode (22.62%) (Figure 11B). In the case of apoptosis assays, the same proportion of increased programmed cell death is shown in both continuous and intermittent exposure modes (C: 17.91%; I: 20.00%), with a very high proportion of non-significant results in both modes (C: 80.60%; I: 80.00%) (Figure 11C). Cells exposed to intermittent magnetic fields (82.35%) show an increase in oxidative stress compared to cells subjected to continuous exposure (57.81%) (Figure 11D). In the case of the cell cycle, the proportions of the occurrence of effects are similar for continuous exposures (30.77%) and intermittent exposures (40.00%) (Figure 11E).

4. Discussion

4.1. Summary of Evidence

The main objective of this review is to highlight the importance of the control of exposure parameters in bioelectromagnetic cellular assays. Each of the parameters studied and included in this review of the scientific literature (frequency, intensity, exposure time, exposure mode) determines the cellular response to certain cellular processes such as those described here (viability, proliferation, apoptosis, oxidative stress and mitochondrial damage and cell cycle). Consequently, the question arises as to which parameter is the most decisive in the cellular response to each of these processes. Although we have observed in the results of this review that there does not seem to be an obvious answer to this question, it is not clear which is the most important one.
For decades, due to the establishment of exposure regulations for low-frequency electromagnetic fields, intensity has been thought to be the determining parameter for most of the effects found in both in vitro and in vivo experiments [139,140,141,142]. The so-called “dose effect”, whereby the probability of effects increases proportionally to the intensity, has been one of the most reinforced theories in the scientific literature [139,140,141,142]. However, biological systems are not linear systems [47,143,144], which leads us to believe that even if the stimulus increases, the response will not. The results of this review show inconclusive results of the occurrence of effects by intensity ranges and therefore do not seem to conform to a dose effect correlation between this parameter and the response to the cellular processes studied (Figure 9).
Frequency has been studied by numerous researchers as a possible cause of resonance effects in the cell that could determine the responses found in in vitro studies [10,53,54,145,146,147,148,149,150,151,152]. Although most studies continue to be performed in the frequency range [50–60] Hz, as this is the range determined for the electricity distribution network in Europe and America, results are obtained for other frequency ranges, as can be seen in Figure 7. Some cell parameters appear to be more sensitive to frequency such as proliferation (Figure 8B), oxidative stress (Figure 8F) and the cell cycle (Figure 8G) in which changes in cell behaviour in different frequency ranges are evident. In turn, time, exposure mode and waveform (which has been left out of this review) seem to be able to determine the behaviour of biological systems. If we look at Figure 10, we can see that a longer duration of exposure does not always lead to a greater occurrence of results; we are, therefore, faced with a new non-linear response of biological systems; an increase in exposure time is not synonymous with an increase in response.
Perhaps the solution is not to think of one parameter as the conductor of the orchestra but rather a combination of these parameters that is specific to each cell type. We would understand this combination of parameters as a code that the cell receives and that sets in motion the different mechanisms of action. Therefore, in view of the results obtained, we reiterate the importance that must be given to the search for the effects that each of these parameters and their different combinations can produce in different cellular strains. One of the main problems in the implementation of cellular experiments of exposure to magnetic fields is that there is no objective quantification of the different parameters, being that the measurement of the frequency, intensity and real waveform that the cell receives on the culture surface is imprecise and inaccurate. This leads to contradictory results between different research groups that use the same cell line, the same intensity and frequency, and even the same waveform, but fail to mimic the methodologies for monitoring these parameters and maintain methodological rigour. For this purpose, a gaussmeter with a triaxial probe must be used that allows for the measurement of the magnetic field in the three spatial components (X,Y,Z) individually and not as a resultant vector. For the characterisation of the magnetic field signals, the gaussmeter must be able to sample the signal in real time. The Fourier transform of the recorded signal should be indicated in the methodology, highlighting the fundamental frequency of the indicated waveform, an analysis of the harmonics of the recorded signal and the type of the intensity measurement peak–peak value or root mean square (RMS) value. This allows for the replicability of the experiments and their reliability in the methodology. In addition, it is important to characterise and indicate in the methodology the intensity values recorded over the whole surface of the culture plate, in order to record inhomogeneities on the biological material surface.
When an attempt is made to group these scientific articles in literature reviews that seek to draw conclusions related to a particular biological process, the main discussion is about the inability to obtain conclusive results and the lack of scientific evidence. In these reviews, generally, the parameters are analysed together without discriminating by frequency, intensity, exposure time, waveform, exposure mode or cell line. These comparisons are not useful for obtaining repeat patterns nor do they feed the search for possible models of interaction between magnetic fields and biological systems. If the exposure parameters are not the same, the comparison is not feasible. This lack of consensus on the exposure parameters of magnetic fields is not the only thing that determines the non-replicability of experiments; the use of different biomarkers and cell types is also a determining factor [39,40]. In this review, a division of results by tumour and non-tumour cell type has been made. It has been decided to separate into these broad groups to support the hypothesis that magnetic fields could have a reproductive response by decreasing or increasing biological processes such as proliferation that determine tumour development. In the results presented, it appears that the type of cellular response may indeed be determined by the nature of the cell (tumour, non-tumour) (Figure 5), with cellular processes such as viability and proliferation returning opposite results depending on the cell type tested (Figure 5A,B). However, it is likely that each cell type shows a different response that cannot be unified into a single combination of parameters depending on whether the cell is tumour or non-tumour or belongs to one tissue or another.
Another aspect that is not often reported in the articles is the values of the background field that exists in the samples at the time of exposure. This value also includes the value of the geomagnetic field of the place where the exposure is taking place. In most articles, these values are not reported, so it is impossible to know the pre-exposure conditions in terms of the magnetic field of the room where the incubators are located and inside the incubator itself. These values have also been shown to influence cell behaviour and therefore the results obtained [39,40,41,153].
So far, the level of statistical significance used in the analysis of experimental data has been considered to support the occurrence of significant cellular effects, but no optimal underlying mechanism is available to explain statistical significance. Some of the proposed mechanisms cite transient radical pairs and triplet phenomena [154,155,156] or resonant effects [10,145,146,147,148,149,150,151,152]. The main theory of the mechanisms of action was based on the induction of electric fields and currents in biological tissues, but many of these phenomena require much lower energy levels at which the occurrence of these effects is limited, which could be explained by the existence of non-linear states. No single interaction model has been determined to cause the effects found, probably due to the interaction of more than one mechanism of action causing the effects. Determining the cellular response to a given combination of exposure parameters is not as simple as applying statistical models and concluding with significant or non-significant effects.
The existence of effects in in vitro assays on different cellular processes studied is a fact that cannot be disregarded because of the inability to draw conclusions in a field as heterogeneous as bioelectromagnetism. What is essential and necessary is the establishment of laboratory methodological rules that ensure replicability, objectivity (understood as the interpretation of results based on experimentation) and methodological rigour in the control of exposure parameters and cell analysis.

4.2. Limitations

This review has been based on the articles contained in only two databases (PubMed and Scopus), which may result in the loss of articles that are not contained in them. Although the search sequence was broad so as not to miss too much of the relevant scientific literature that met the characteristics of our inclusion criteria, it is possible that important references may have been lost due to the use of the two databases chosen.
Cell grouping for the determination of the effects has been performed on the bulk of two cell populations, tumour (T) cells and non-tumour (NT) cells; however, it would be logical and accurate to study each of these effects for each of the possible differences between lines, to begin with, the division between human cells and animal cells, also whether they are primary or immortalised cell lines, following with suspension or adherent cell lines’ division and, finally, with the type of tissue to which each of the lines used belongs. This content could be used for a future review on how biological issues affect the results, which are decisive in the design of the experiments.
Some of the division ranges for each of the parameters did not have data with which to carry out the statistics, so the statistics in these cases are incomplete.
No discrimination was made by exposure equipment, the type of coil used or laboratory conditions at the time of exposure (ambient magnetic fields), which could alter the results obtained based on the device used.
We consider that in order to draw conclusions about how parameters can determine the cellular response, it is not only important, as in this review, to make statistical groupings of effects but also to establish mechanisms of action that can explain how each of these parameters interacts with the cellular components.

5. Conclusions

This review arises from the need to consider each of the parameters of exposure to magnetic fields as an entity capable of producing a determined response in the cell. The importance that has been given to the intensity parameter since the establishment of regulations for the exposure of the general public to low-frequency electromagnetic fields has led to it also being the main parameter in in vitro experiments, considering intensity as the determining parameter for the occurrence of the main cellular effects and placing the “dose effect” as one of the main theories explaining the effects found. We must begin to think of combinations of exposure parameters that act at the cellular level as specific codes that give rise to specific responses. Biology, and more specifically cell biology, entails a set of rules that must be protected as a fundamental right. There must be a commitment on the part of scientific researchers in bioelectromagnetism to develop quality experiments based on rigorous working methodologies and the search for experimental conclusions that contribute to existing knowledge in this field in order to establish models of interaction between magnetic fields and biological systems that allow us to think of magnetic fields not only as a tool for modulating cell behaviour but also as a possible therapeutic application for various fields of medicine such as oncology, neurodegeneration or the healing of wounds and lesions.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/ijms25105074/s1.

Author Contributions

I.L.d.M.: bibliographic search. The reading of articles and the summary in tables. Article writing. Graphics. The summary tables of this review. Discussion. M.-X.R.G.: bibliographic search, discussion and manuscript review. C.M.U.: article reading and summary tables, discussion and manuscript review. Review supervision and direction. All authors have read and agreed to the published version of the manuscript.

Funding

This work has been financially supported by the Fundación Humanismo y Ciencia within the project ‘Evaluation of the in vitro effects produced by low frequency electromagnetic fields’ developed in the Bioelectromagnetism laboratory of the Centro de Tecnología Biomédica of the Universidad Politécnica de Madrid (Project number: P220060173).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data are contained within this article or the Supplementary Material.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Blackman, C.F.; Benane, S.G.; Kinney, L.S.; Joines, W.T.; House, D.E. Effects of ELF Fields on Calcium-Ion Efflux from Brain Tissue in Vitro. Radiat. Res. 1982, 92, 510–520. [Google Scholar] [CrossRef] [PubMed]
  2. Blackman, C.F.; Benane, S.G.; House, D.E.; Joines, W.T. Effects of ELF (1–120 Hz) and Modulated (50 Hz) RF Fields on the Efflux of Calcium Ions from Brain Tissue in Vitro. Bioelectromagnetics 1985, 6, 1–11. [Google Scholar] [CrossRef] [PubMed]
  3. Blackman, C.F.; Benane, S.G.; Rabinowitz, J.R.; House, D.E.; Joines, W.T. A Role for the Magnetic Field in the Radiation-induced Efflux of Calcium Ions from Brain Tissue in Vitro. Bioelectromagnetics 1985, 6, 327–337. [Google Scholar] [CrossRef] [PubMed]
  4. Goodman, R.; Henderson, A.S. Sine Waves Enhance Cellular Transcription. Bioelectromagnetics 1986, 7, 23–29. [Google Scholar] [CrossRef] [PubMed]
  5. Goodman, R.; Bassett, C.A.L.; Henderson, A.S. Pulsing Electromagnetic Fields Induce Cellular Transcription. Science 1983, 220, 1283–1285. [Google Scholar] [CrossRef]
  6. Liboff, A.R.; Williams, T.; Strong, D.M.; Wistar, R. Time-Varying Magnetic Fields: Effect on DNA Synthesis. Science 1984, 223, 818–820. [Google Scholar] [CrossRef] [PubMed]
  7. Luben, R.A.; Cain, C.D.; Chen, M.C.-Y.; Rosen, D.M.; Adey, W.R. Effects of Electromagnetic Stimuli on Bone and Bone Cells in Vitro: Inhibition of Responses to Parathyroid Hormone by Low-Energy Low-Frequency Fields. Proc. Natl. Acad. Sci. USA 1982, 79, 4180–4184. [Google Scholar] [CrossRef]
  8. Mooney, N.A.; Smith, R.E.; Watson, B.W. Effect of Extremely-low-frequency Pulsed Magnetic Fields on the Mitogenic Response of Peripheral Blood Mononuclear Cells. Bioelectromagnetics 1986, 7, 387–394. [Google Scholar] [CrossRef] [PubMed]
  9. Frazier, M.E.; Reese, J.A.; Morris, J.E.; Jostes, R.F.; Miller, D.L. Exposure of Mammalian Cells to 60-Hz Magnetic or Electric Fields: Analysis of DNA Repair of Induced, Single-strand Breaks. Bioelectromagnetics 1990, 11, 229–234. [Google Scholar] [CrossRef]
  10. Liboff, A.R.; Parkinson, W.C. Search for Ion-cyclotron Resonance in an Na+-transport System. Bioelectromagnetics 1991, 12, 77–83. [Google Scholar] [CrossRef]
  11. Goodman, E.M.; Sharpe, P.T.; Greenebaum, B.; Marron, M.T. Pulsed Magnetic Fields Alter the Cell Surface. FEBS Lett. 1986, 199, 275–278. [Google Scholar] [CrossRef]
  12. International Commission on Non-Ionizing Radiation Protection (ICNIRP). Guidelines for Limiting Exposure to Time-Varying Electric, Magnetic, and Electromagnetic Fields (up to 300 GHz). Health Phys. 1998, 74, 494–522. [Google Scholar]
  13. Piszczek, P.; Wójcik-Piotrowicz, K.; Gil, K.; Kaszuba-Zwoińska, J. Immunity and Electromagnetic Fields. Environ. Res. 2021, 200, 111505. [Google Scholar] [CrossRef] [PubMed]
  14. Zhang, G.; Liu, X.; Liu, Y.; Zhang, S.; Yu, T.; Chai, X.; He, J.; Yin, D.; Zhang, C. The Effect of Magnetic Fields on Tumor Occurrence and Progression: Recent Advances. Prog. Biophys. Mol. Biol. 2023, 179, 38–50. [Google Scholar] [CrossRef]
  15. Golbach, L.A.; Portelli, L.A.; Savelkoul, H.F.J.; Terwel, S.R.; Kuster, N.; de Vries, R.B.M.; Verburg-van Kemenade, B.M.L. Calcium Homeostasis and Low-Frequency Magnetic and Electric Field Exposure: A Systematic Review and Meta-Analysis of in Vitro Studies. Environ. Int. 2016, 92–93, 695–706. [Google Scholar] [CrossRef] [PubMed]
  16. Ma, T.; Ding, Q.; Liu, C.; Wu, H. Electromagnetic Fields Regulate Calcium-Mediated Cell Fate of Stem Cells: Osteogenesis, Chondrogenesis and Apoptosis. Stem Cell Res. Ther. 2023, 14, 133. [Google Scholar] [CrossRef]
  17. Wang, H.; Zhang, X. Magnetic Fields and Reactive Oxygen Species. Int. J. Mol. Sci. 2017, 18, 2175. [Google Scholar] [CrossRef]
  18. Montoya, R.D. Magnetic Fields, Radicals and Cellular Activity. Electromagn. Biol. Med. 2017, 36, 102–113. [Google Scholar] [CrossRef]
  19. Vadalà, M.; Morales-Medina, J.C.; Vallelunga, A.; Palmieri, B.; Laurino, C.; Iannitti, T. Mechanisms and Therapeutic Effectiveness of Pulsed Electromagnetic Field Therapy in Oncology. Cancer Med. 2016, 5, 3128–3139. [Google Scholar] [CrossRef]
  20. Maffei, M.E. Magnetic Fields and Cancer: Epidemiology, Cellular Biology, and Theranostics. Int. J. Mol. Sci. 2022, 23, 1339. [Google Scholar] [CrossRef]
  21. Löscher, W.; Liburdy, R.P. Animal and Cellular Studies on Carcinogenic Effects of Low Frequency (50/60-Hz) Magnetic Fields 1 This Is the Last in a Series of Four Papers, the First of Which Was Published in Mutation Res. 387 (1997) pp. 165–171.1. Mutat. Res./Rev. Mutat. Res. 1998, 410, 185–220. [Google Scholar] [CrossRef] [PubMed]
  22. Kavet, R. EMF and Current Cancer Concepts. Bioelectromagnetics 1996, 17, 339–357. [Google Scholar] [CrossRef]
  23. Kocaman, A.; Altun, G.; Kaplan, A.A.; Deniz, Ö.G.; Yurt, K.K.; Kaplan, S. Genotoxic and Carcinogenic Effects of Non-Ionizing Electromagnetic Fields. Environ. Res. 2018, 163, 71–79. [Google Scholar] [CrossRef] [PubMed]
  24. Diab, K.A. The Impact of the Low Frequency of the Electromagnetic Field on Human. In Advances in Experimental Medicine and Biology; Springer: Berlin/Heidelberg, Germany, 2020; Volume 1237, pp. 135–149. [Google Scholar]
  25. Duan, Y.; Wu, X.; Gong, Z.; Guo, Q.; Kong, Y. Pathological Impact and Medical Applications of Electromagnetic Field on Melanoma: A Focused Review. Front. Oncol. 2022, 12, 857068. [Google Scholar] [CrossRef] [PubMed]
  26. Goldberg, R.B.; Creasey, W.A. A Review of Cancer Induction by Extremely Low Frequency Electromagnetic Fields. Is There a Plausible Mechanism? Med. Hypotheses 1991, 35, 265–274. [Google Scholar] [CrossRef] [PubMed]
  27. Holmberg, B. Magnetic Fields and Cancer: Animal and Cellular Evidence—An Overview. Environ. Health Perspect. 1995, 103, 63–67. [Google Scholar] [CrossRef] [PubMed]
  28. Lei, H.; Pan, Y.; Wu, R.; Lv, Y. Innate Immune Regulation Under Magnetic Fields With Possible Mechanisms and Therapeutic Applications. Front. Immunol. 2020, 11, 582772. [Google Scholar] [CrossRef]
  29. Simkó, M.; Mattsson, M.O. Extremely Low Frequency Electromagnetic Fields as Effectors of Cellular Responses in Vitro: Possible Immune Cell Activation. J. Cell Biochem. 2004, 93, 83–92. [Google Scholar] [CrossRef]
  30. Walleczek, J. Electromagnetic Field Effects on Cells of the Immune System: The Role of Calcium Signaling. FASEB J. 1992, 6, 3177–3185. [Google Scholar] [CrossRef]
  31. Simkó, M. Induction of Cell Activation Processes by Low Frequency Electromagnetic Fields. Sci. World J. 2004, 4 (Suppl. S2), 4–22. [Google Scholar] [CrossRef]
  32. Mahaki, H.; Tanzadehpanah, H.; Jabarivasal, N.; Sardanian, K.; Zamani, A. A Review on the Effects of Extremely Low Frequency Electromagnetic Field (ELF-EMF) on Cytokines of Innate and Adaptive Immunity. Electromagn. Biol. Med. 2019, 38, 84–95. [Google Scholar] [CrossRef] [PubMed]
  33. Lopez-Martin, M.E.; Sueiro-Benavides, R.A.; Leiro-Vidal, J.M.; Rodriguez-Gonzalez, J.A.; Ares-Pena, F.J. Can Electromagnetic Fields Modulate Inflammation and Cell Death by Acting on the Immune System? IEEE Access 2023, 11, 92167–92187. [Google Scholar] [CrossRef]
  34. Guerriero, F.; Ricevuti, G. Extremely Low Frequency Electromagnetic Fields Stimulation Modulates Autoimmunity and Immune Responses: A Possible Immuno-Modulatory Therapeutic Effect in Neurodegenerative Diseases. Neural Regen. Res. 2016, 11, 1888–1895. [Google Scholar] [CrossRef] [PubMed]
  35. Rosado, M.M.; Simkó, M.; Mattsson, M.O.; Pioli, C. Immune-Modulating Perspectives for Low Frequency Electromagnetic Fields in Innate Immunity. Front. Public Health 2018, 6, 323464. [Google Scholar] [CrossRef] [PubMed]
  36. Saliev, T.; Begimbetova, D.; Masoud, A.R.; Matkarimov, B. Biological Effects of Non-Ionizing Electromagnetic Fields: Two Sides of a Coin. Prog. Biophys. Mol. Biol. 2019, 141, 25–36. [Google Scholar] [CrossRef] [PubMed]
  37. Bassett, C.A.L. Beneficial Effects of Electromagnetic Fields. J. Cell Biochem. 1993, 51, 387–393. [Google Scholar] [CrossRef] [PubMed]
  38. Lai, H. Genetic Effects of Non-Ionizing Electromagnetic Fields. Electromagn. Biol. Med. 2021, 40, 264–273. [Google Scholar] [CrossRef]
  39. Valberg, P.A. Designing EMF Experiments: What Is Required to Characterize “Exposure”? Bioelectromagnetics 1995, 16, 396–401. [Google Scholar] [CrossRef] [PubMed]
  40. Misakian, M.; Kaune, W.T. Optimal Experimental Design for in Vitro Studies with ELF Magnetic Fields. Bioelectromagnetics 1990, 11, 251–255. [Google Scholar] [CrossRef]
  41. Misakian, M.; Sheppard, A.R.; Krause, D.; Frazier, M.E.; Miller, D.L. Biological, Physical, and Electrical Parameters for in Vitro Studies with ELF Magnetic and Electric Fields: A Primer. Bioelectromagnetics 1993, 14, 1–73. [Google Scholar] [CrossRef]
  42. Ruiz-Gómez, M.J.; Martínez-Morillo, M. Electromagnetic Fields and the Induction of DNA Strand Breaks. Electromagn. Biol. Med. 2009, 28, 201–214. [Google Scholar] [CrossRef] [PubMed]
  43. Vijayalaxmi; Obe, G. Controversial Cytogenetic Observations in Mammalian Somatic Cells Exposed to Extremely Low Frequency Electromagnetic Radiation: A Review and Future Research Recommendations. Bioelectromagnetics 2005, 26, 412–430. [Google Scholar] [CrossRef] [PubMed]
  44. Barati, M.; Darvishi, B.; Javidi, M.A.; Mohammadian, A.; Shariatpanahi, S.P.; Eisavand, M.R.; Madjid Ansari, A. Cellular Stress Response to Extremely Low-Frequency Electromagnetic Fields (ELF-EMF): An Explanation for Controversial Effects of ELF-EMF on Apoptosis. Cell Prolif. 2021, 54, e13154. [Google Scholar] [CrossRef] [PubMed]
  45. Costin, G.-E.; Birlea, S.A.; Norris, D.A. Trends in Wound Repair: Cellular and Molecular Basis of Regenerative Therapy Using Electromagnetic Fields. Curr. Mol. Med. 2012, 12, 14–26. [Google Scholar] [CrossRef]
  46. Adey, W.R. Biological Effects of Electromagnetic Fields. J. Cell Biochem. 1993, 51, 410–416. [Google Scholar] [CrossRef] [PubMed]
  47. Azanza, M.J.; del Moral, A. Cell Membrane Biochemistry and Neurobiological Approach to Biomagnetism. Prog. Neurobiol. 1994, 44, 517–601. [Google Scholar] [CrossRef] [PubMed]
  48. Barnes, F.S. Some Engineering Models for Interactions of Electric and Magnetic Fields with Biological Systems. Bioelectromagnetics 1992, 13, 67–85. [Google Scholar] [CrossRef]
  49. Grundler, W.; Kaiser, F.; Keilmann, F.; Walleczek, J. Mechanisms of Electromagnetic Interaction with Cellular Systems. Naturwissenschaften 1992, 79, 551–559. [Google Scholar] [CrossRef] [PubMed]
  50. Pilla, A.A.; Markov, M.S. Bioeffects of Weak Electromagnetic Fields. Rev. Environ. Health 1994, 10, 155–170. [Google Scholar] [CrossRef]
  51. Krylov, V.V.; Osipova, E.A. Molecular Biological Effects of Weak Low-Frequency Magnetic Fields: Frequency–Amplitude Efficiency Windows and Possible Mechanisms. Int. J. Mol. Sci. 2023, 24, 10989. [Google Scholar] [CrossRef]
  52. Lednev, V.V. Possible Mechanism for the Influence of Weak Magnetic Fields on Biological Systems. Bioelectromagnetics 1991, 12, 71–75. [Google Scholar] [CrossRef] [PubMed]
  53. Adey, W.R. Tissue Interactions with Nonionizing Electromagnetic Fields. Physiol. Rev. 1981, 61, 435–514. [Google Scholar] [CrossRef] [PubMed]
  54. Bawin, S.M.; Sheppard, A.; Adey, W.R. 203—Possible Mechanisms of Weak Electromagnetic Field Coupling in Brain Tissue. Bioelectrochem. Bioenerg. 1978, 5, 67–76. [Google Scholar] [CrossRef]
  55. García-minguillán, O.; Maestú, C. 30 Hz, Could It Be Part of a Window Frequency for Cellular Response? Int. J. Mol. Sci. 2021, 22, 3642. [Google Scholar] [CrossRef]
  56. Maziarz, A.; Kocan, B.; Bester, M.; Budzik, S.; Cholewa, M.; Ochiya, T.; Banas, A. How Electromagnetic Fields Can Influence Adult Stem Cells: Positive and Negative Impacts. Stem Cell Res. Ther. 2016, 7, 54. [Google Scholar] [CrossRef] [PubMed]
  57. Klimek, A.; Rogalska, J. Extremely Low-Frequency Magnetic Field as a Stress Factor—Really Detrimental?—Insight into Literature from the Last Decade. Brain Sci. 2021, 11, 174. [Google Scholar] [CrossRef] [PubMed]
  58. Lacy-hulbert, A.; Metcalfe, J.C.; Hesketh, R. Biological Responses to Electromagnetic Fields. FASEB J. 1998, 12, 395–420. [Google Scholar] [CrossRef] [PubMed]
  59. Lai, H.; Levitt, B.B. Cellular and molecular effects of non-ionizing electromagnetic fields. Rev. Environ. Health 2023. [Google Scholar] [CrossRef] [PubMed]
  60. Lee, S.K.; Park, S.; Gimm, Y.M.; Kim, Y.W. Extremely Low Frequency Magnetic Fields Induce Spermatogenic Germ Cell Apoptosis: Possible Mechanism. Biomed. Res. Int. 2014, 2014, 567183. [Google Scholar] [CrossRef]
  61. Lai, H. Exposure to Static and Extremely-Low Frequency Electromagnetic Fields and Cellular Free Radicals. Electromagn. Biol. Med. 2019, 38, 231–248. [Google Scholar] [CrossRef]
  62. Schuermann, D.; Mevissen, M. Manmade Electromagnetic Fields and Oxidative Stress—Biological Effects and Consequences for Health. Int. J. Mol. Sci. 2021, 22, 3772. [Google Scholar] [CrossRef] [PubMed]
  63. Perez, F.P.; Bandeira, J.P.; Perez Chumbiauca, C.N.; Lahiri, D.K.; Morisaki, J.; Rizkalla, M. Multidimensional Insights into the Repeated Electromagnetic Field Stimulation and Biosystems Interaction in Aging and Age-Related Diseases. J. Biomed. Sci. 2022, 29, 39. [Google Scholar]
  64. Luben, R.A. Effects of Low-Energy Electromagnetic Fields (Pulsed and DC) on Membrane Signal Transduction Processes in Biological Systems. Health Phys. 1991, 61, 15–28. [Google Scholar] [CrossRef] [PubMed]
  65. Saliev, T.; Mustapova, Z.; Kulsharova, G.; Bulanin, D.; Mikhalovsky, S. Therapeutic Potential of Electromagnetic Fields for Tissue Engineering and Wound Healing. Cell Prolif. 2014, 47, 485–493. [Google Scholar] [CrossRef] [PubMed]
  66. Gualdi, G.; Costantini, E.; Reale, M.; Amerio, P. Wound Repair and Extremely Low Frequency-Electromagnetic Field: Insight from In Vitro Study and Potential Clinical Application. Int. J. Mol. Sci. 2021, 22, 5037. [Google Scholar] [CrossRef] [PubMed]
  67. Wang, T.; Xie, W.; Ye, W.; He, C. Effects of Electromagnetic Fields on Osteoarthritis. Biomed. Pharmacother. 2019, 118, 109282. [Google Scholar] [CrossRef] [PubMed]
  68. Otter, M.W.; McLeod, K.J.; Rubin, C.T. Effects of Electromagnetic Fields in Experimental Fracture Repair. Clin. Orthop. Relat. Res. 1998, 355, S90–S104. [Google Scholar] [CrossRef] [PubMed]
  69. Ross, C.L.; Siriwardane, M.; Almeida-Porada, G.; Porada, C.D.; Brink, P.; Christ, G.J.; Harrison, B.S. The Effect of Low-Frequency Electromagnetic Field on Human Bone Marrow Stem/Progenitor Cell Differentiation. Stem Cell Res. 2015, 15, 96–108. [Google Scholar] [CrossRef] [PubMed]
  70. Galli, C.; Colangelo, M.; Pedrazzi, G.; Guizzardi, S. The Response of Osteoblasts and Bone to Sinusoidal Electromagnetic Fields: Insights from the Literature. Calcif. Tissue Int. 2019, 105, 127–147. [Google Scholar] [CrossRef]
  71. Yuan, J.; Xin, F.; Jiang, W. Underlying Signaling Pathways and Therapeutic Applications of Pulsed Electromagnetic Fields in Bone Repair. Cell. Physiol. Biochem. 2018, 46, 1581–1594. [Google Scholar] [CrossRef]
  72. Moya Gómez, A.; Font, L.P.; Brône, B.; Bronckaers, A. Electromagnetic Field as a Treatment for Cerebral Ischemic Stroke. Front. Mol. Biosci. 2021, 8, 742596. [Google Scholar] [CrossRef]
  73. Tricco, A.C.; Lillie, E.; Zarin, W.; O’Brien, K.K.; Colquhoun, H.; Levac, D.; Moher, D.; Peters, M.D.J.; Horsley, T.; Weeks, L.; et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann. Intern. Med. 2018, 169, 467–473. [Google Scholar] [CrossRef]
  74. Nezamtaheri, M.S.; Goliaei, B.; Shariatpanahi, S.P.; Ansari, A.M. Differential Biological Responses of Adherent and Non-Adherent (Cancer and Non-Cancerous) Cells to Variable Extremely Low Frequency Magnetic Fields. Sci. Rep. 2022, 12, 14225. [Google Scholar] [CrossRef]
  75. Koziorowska, A.; Romerowicz-Misielak, M.; Sołek, P.; Koziorowski, M. Extremely Low Frequency Variable Electromagnetic Fields Affect Cancer and Noncancerous Cells in Vitro Differently: Preliminary Study. Electromagn. Biol. Med. 2018, 37, 35–42. [Google Scholar] [CrossRef]
  76. Ledda, M.; D’emilia, E.; Lolli, M.G.; Marchese, R.; De Lazzari, C.; Lisi, A. Non-Ionizing Radiation for Cardiac Human Amniotic Mesenchymal Stromal Cell Commitment: A Physical Strategy in Regenerative Medicine. Int. J. Mol. Sci. 2018, 19, 2324. [Google Scholar] [CrossRef] [PubMed]
  77. López, O.G.M.; Valbuena, A.J.; Unturbe, C.M. Significant Cellular Viability Dependence on Time Exposition at ELF-EMF and RF-EMF in Vitro Studies. Int. J. Environ. Res. Public. Health 2019, 16, 2085. [Google Scholar] [CrossRef] [PubMed]
  78. García-minguillán, O.; Prous, R.; Ramirez-castillejo, M.D.C.; Maestú, C. CT2A Cell Viability Modulated by Electromagnetic Fields at Extremely Low Frequency under No Thermal Effects. Int. J. Mol. Sci. 2020, 21, 152. [Google Scholar] [CrossRef] [PubMed]
  79. Wang, M.H.; Chen, K.W.; Ni, D.X.; Fang, H.J.; Jang, L.S.; Chen, C.H. Effect of Extremely Low Frequency Electromagnetic Field Parameters on the Proliferation of Human Breast Cancer. Electromagn. Biol. Med. 2021, 40, 384–392. [Google Scholar] [CrossRef]
  80. Yin, C.; Luo, X.; Duan, Y.; Duan, W.; Zhang, H.; He, Y.; Sun, G.; Sun, X. Neuroprotective Effects of Lotus Seedpod Procyanidins on Extremely Low Frequency Electromagnetic Field-Induced Neurotoxicity in Primary Cultured Hippocampal Neurons. Biomed. Pharmacother. 2016, 82, 628–639. [Google Scholar] [CrossRef]
  81. Cho, S.; Lee, Y.; Lee, S.; Choi, Y.J.; Chung, H.W. Enhanced Cytotoxic and Genotoxic Effects of Gadolinium Following ELF-EMF Irradiation in Human Lymphocytes. Drug Chem. Toxicol. 2014, 37, 440–447. [Google Scholar] [CrossRef]
  82. de Groot, M.W.G.D.M.; van Kleef, R.G.D.M.; de Groot, A.; Westerink, R.H.S. Developmental Neurotoxicity Following Chronic Exposure to 50 Hz Extremely Low-Frequency Electromagnetic Fields in Primary Rat Cortical Cultures. Toxicol. Sci. 2016, 149, 433–440. [Google Scholar] [CrossRef] [PubMed]
  83. Calcabrini, C.; Mancini, U.; De Bellis, R.; Diaz, A.R.; Martinelli, M.; Cucchiarini, L.; Sestili, P.; Stocchi, V.; Potenza, L. Effect of Extremely Low-Frequency Electromagnetic Fields on Antioxidant Activity in the Human Keratinocyte Cell Line NCTC 2544. Biotechnol. Appl. Biochem. 2017, 64, 415–422. [Google Scholar] [CrossRef]
  84. Morabito, C.; Steimberg, N.; Rovetta, F.; Boniotti, J.; Guarnieri, S.; Mazzoleni, G.; Mariggiò, M.A. Extremely Low-Frequency Electromagnetic Fields Affect Myogenic Processes in C2C12 Myoblasts: Role of Gap-Junction-Mediated Intercellular Communication. Biomed. Res. Int. 2017, 2017, 2460215. [Google Scholar] [CrossRef]
  85. Ma, Q.; Deng, P.; Zhu, G.; Liu, C.; Zhang, L.; Zhou, Z.; Luo, X.; Li, M.; Zhong, M.; Yu, Z.; et al. Extremely Low-Frequency Electromagnetic Fields Affect Transcript Levels of Neuronal Differentiation-Related Genes in Embryonic Neural Stem Cells. PLoS ONE 2014, 9, e90041. [Google Scholar] [CrossRef]
  86. Costantini, E.; Marconi, G.D.; Fonticoli, L.; Aielli, L.; Trubiani, O.; Rajan, T.S.; Pizzicannella, J.; Reale, M.; Diomede, F. Improved Osteogenic Differentiation by Extremely Low Electromagnetic Field Exposure: Possible Application for Bone Engineering. Histochem. Cell Biol. 2022, 158, 369–381. [Google Scholar] [CrossRef] [PubMed]
  87. Duan, W.; Liu, C.; Zhang, L.; He, M.; Xu, S.; Chen, C.; Pi, H.; Gao, P.; Zhang, Y.; Zhong, M.; et al. Comparison of the Genotoxic Effects Induced by 50 Hz Extremely Low-Frequency Electromagnetic Fields and 1800 MHz Radiofrequency Electromagnetic Fields in GC-2 Cells. Radiat. Res. 2015, 183, 305–314. [Google Scholar] [CrossRef] [PubMed]
  88. Park, J.E.; Seo, Y.K.; Yoon, H.H.; Kim, C.W.; Park, J.K.; Jeon, S. Electromagnetic Fields Induce Neural Differentiation of Human Bone Marrow Derived Mesenchymal Stem Cells via ROS Mediated EGFR Activation. Neurochem. Int. 2013, 62, 418–424. [Google Scholar] [CrossRef]
  89. Song, K.; Im, S.H.; Yoon, Y.J.; Kim, H.M.; Lee, H.J.; Park, G.S. A 60 Hz Uniform Electromagnetic Field Promotes Human Cell Proliferation by Decreasing Intracellular Reactive Oxygen Species Levels. PLoS ONE 2018, 13, e0199753. [Google Scholar] [CrossRef]
  90. Garip, A.; Akan, Z. Effect of ELF-EMF on Number of Apoptotic Cells; Correlation with Reactive Oxygen Species and HSP. Acta Biol. Hung. 2010, 61, 158–167. [Google Scholar] [CrossRef]
  91. Vianale, G.; Reale, M.; Amerio, P.; Stefanachi, M.; Di Luzio, S.; Muraro, R. Extremely Low Frequency Electromagnetic Field Enhances Human Keratinocyte Cell Growth and Decreases Proinflammatory Chemokine Production. Br. J. Dermatol. 2008, 158, 1189–1196. [Google Scholar] [CrossRef]
  92. Morabito, C.; Guarnieri, S.; Fanò, G.; Mariggiò, M.A. Effects of Acute and Chronic Low Frequency Electromagnetic Field Exposure on PC12 Cells during Neuronal Differentiation. Cell. Physiol. Biochem. 2010, 26, 947–958. [Google Scholar] [CrossRef] [PubMed]
  93. Reale, M.; Kamal, M.A.; Patruno, A.; Costantini, E.; D’Angelo, C.; Pesce, M.; Greig, N.H. Neuronal Cellular Responses to Extremely Low Frequency Electromagnetic Field Exposure: Implications Regarding Oxidative Stress and Neurodegeneration. PLoS ONE 2014, 9, e104973. [Google Scholar] [CrossRef] [PubMed]
  94. Falone, S.; Grossi, M.R.; Cinque, B.; D’Angelo, B.; Tettamanti, E.; Cimini, A.; Di Ilio, C.; Amicarelli, F. Fifty Hertz Extremely Low-Frequency Electromagnetic Field Causes Changes in Redox and Differentiative Status in Neuroblastoma Cells. Int. J. Biochem. Cell Biol. 2007, 39, 2093–2106. [Google Scholar] [CrossRef]
  95. Akbarnejad, Z.; Eskandary, H.; Vergallo, C.; Nematollahi-Mahani, S.N.; Dini, L.; Darvishzadeh-Mahani, F.; Ahmadi, M. Effects of Extremely Low-Frequency Pulsed Electromagnetic Fields (ELF-PEMFs) on Glioblastoma Cells (U87). Electromagn. Biol. Med. 2017, 36, 238–247. [Google Scholar] [CrossRef]
  96. Shoorche, A.B.; Mohammadkarim, A.; Jadidi, M.; Bahraminasab, M.; Bagheri, H.; Gholami, S. Human Osteosarcoma Cells in Response to ELF-MF: Morphological Remodeling Compared to Cell Proliferation. J. Cancer Res. Ther. 2023, 19, 1311–1315. [Google Scholar] [CrossRef] [PubMed]
  97. Rahimi, S.; Ahrabi, M.; Samiei, M.; Roshangar, L.; Ahrabi, B.; Hashemi, B.; Shahi, S.; Rahimi Darehchi, N. The Effect of Low-Frequency Pulsed Electromagnetic Fields on the Differentiation of Permanent Dental Pulp Stem Cells into Odontoblasts. Iran. Endod. J. 2023, 18, 218–223. [Google Scholar] [CrossRef]
  98. Razavi, S.; Salimi, M.; Shahbazi-Gahrouei, D.; Karbasi, S.; Kermani, S. Extremely Low-Frequency Electromagnetic Field Influences the Survival and Proliferation Effect of Human Adipose Derived Stem Cells. Adv. Biomed. Res. 2014, 3, 25. [Google Scholar] [CrossRef]
  99. Focke, F.; Schuermann, D.; Kuster, N.; Schär, P. DNA Fragmentation in Human Fibroblasts under Extremely Low Frequency Electromagnetic Field Exposure. Mutat. Res.—Fundam. Mol. Mech. Mutagen. 2010, 683, 74–83. [Google Scholar] [CrossRef] [PubMed]
  100. Grant, D.N.; Cozad, M.J.; Grant, D.A.; White, R.A.; Grant, S.A. In Vitro Electromagnetic Stimulation to Enhance Cell Proliferation in Extracellular Matrix Constructs with and without Metallic Nanoparticles. J. Biomed. Mater. Res. B Appl. Biomater. 2015, 103, 1532–1540. [Google Scholar] [CrossRef]
  101. Cios, A.; Ciepielak, M.; Stankiewicz, W.; Szymański, Ł. The Influence of the Extremely Low Frequency Electromagnetic Field on Clear Cell Renal Carcinoma. Int. J. Mol. Sci. 2021, 22, 1342. [Google Scholar] [CrossRef]
  102. Ross, C.L.; Pettenati, M.J.; Procita, J.; Cathey, L.; George, S.K.; Almeida-Porada, G. Evaluation of Cytotoxic and Genotoxic Effects of Extremely Low-Frequency Electromagnetic Field on Mesenchymal Stromal Cells. Glob. Adv. Health Med. 2018, 7, 1–7. [Google Scholar] [CrossRef] [PubMed]
  103. Liu, Y.; Liu, W.B.; Liu, K.J.; Ao, L.; Cao, J.; Zhong, J.L.; Liu, J.Y. Extremely Low-Frequency Electromagnetic Fields Affect the MiRNA-Mediated Regulation of Signaling Pathways in the GC-2 Cell Line. PLoS ONE 2015, 10, e0139949. [Google Scholar] [CrossRef] [PubMed]
  104. Samiei, M.; Aghazadeh, Z.; Abdolahinia, E.D.; Vahdati, A.; Daneshvar, S.; Noghani, A. The Effect of Electromagnetic Fields on Survival and Proliferation Rate of Dental Pulp Stem Cells. Acta Odontol. Scand. 2020, 78, 494–500. [Google Scholar] [CrossRef]
  105. Ma, Q.; Chen, C.; Deng, P.; Zhu, G.; Lin, M.; Zhang, L.; Xu, S.; He, M.; Lu, Y.; Duan, W.; et al. Extremely Low-Frequency Electromagnetic Fields Promote in Vitro Neuronal Differentiation and Neurite Outgrowth of Embryonic Neural Stem Cells via up- Regulating TRPC1. PLoS ONE 2016, 11, e0150923. [Google Scholar] [CrossRef] [PubMed]
  106. Mehdizadeh, R.; Madjid Ansari, A.; Forouzesh, F.; Shahriari, F.; Shariatpanahi, S.P.; Salaritabar, A.; Javidi, M.A. P53 Status, and G2/M Cell Cycle Arrest, Are Determining Factors in Cell-Death Induction Mediated by ELF-EMF in Glioblastoma. Sci. Rep. 2023, 13, 10845. [Google Scholar] [CrossRef] [PubMed]
  107. Lekovic, M.H.; Drekovic, N.E.; Granica, N.D.; Mahmutovic, E.H.; Djordjevic, N.Z. Extremely Low-Frequency Electromagnetic Field Induces a Change in Proliferative Capacity and Redox Homeostasis of Human Lung Fibroblast Cell Line MRC-5. Environ. Sci. Pollut. Res. 2020, 27, 39466–39473. [Google Scholar] [CrossRef]
  108. Fathi, E.; Farahzadi, R. Zinc Sulphate Mediates the Stimulation of Cell Proliferation of Rat Adipose Tissue-Derived Mesenchymal Stem Cells Under High Intensity of EMF Exposure. Biol. Trace Elem. Res. 2018, 184, 529–535. [Google Scholar] [CrossRef] [PubMed]
  109. AyeŞ, I.G.; Zafer, A.; Şule, O.; IŞil, I.T.; Kalkan, T. Differentiation of K562 Cells under ELF-EMF Applied at Different Time Courses. Electromagn. Biol. Med. 2010, 29, 122–130. [Google Scholar] [CrossRef]
  110. Choi, J.H.; Kim, Y.M.; Park, H.J.; Nam, M.H.; Seo, Y.K. Extremely Low-Frequency Electromagnetic Fields Increase Cytokines in Human Hair Follicles through Wnt/β-Catenin Signaling. Biomedicines 2022, 10, 924. [Google Scholar] [CrossRef]
  111. Ki, G.E.; Kim, Y.M.; Lim, H.M.; Lee, E.C.; Choi, Y.K.; Seo, Y.K. Extremely Low-Frequency Electromagnetic Fields Increase the Expression of Anagen-Related Molecules in Human Dermal Papilla Cells via GSK-3Β/ERK/Akt Signaling Pathway. Int. J. Mol. Sci. 2020, 21, 784. [Google Scholar] [CrossRef]
  112. Restrepo, A.F.; Tobar, V.E.; Camargo, R.J.; Franco, E.; Pinedo, C.R.; Gutierrez, O. Effects of Extremely Low Frequency Electromagnetic Fields on In-Vitro Cellular Cultures HeLa and CHO. In Proceedings of the 2016 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), Orlando, FL, USA, 16–20 August 2016; IEEE: Piscataway, NJ, USA, 2016; pp. 4193–4196. [Google Scholar]
  113. Falone, S.; Marchesi, N.; Osera, C.; Fassina, L.; Comincini, S.; Amadio, M.; Pascale, A. Pulsed Electromagnetic Field (PEMF) Prevents pro-Oxidant Effects of H2O2 in SK-N-BE(2) Human Neuroblastoma Cells. Int. J. Radiat. Biol. 2016, 92, 281–286. [Google Scholar] [CrossRef] [PubMed]
  114. Fan, W.; Qian, F.; Ma, Q.; Zhang, P.; Chen, T.; Chen, C.; Zhang, Y.; Deng, P.; Zhou, Z.; Yu, Z. 50 Hz Electromagnetic Field Exposure Promotes Proliferation and Cytokine Production of Bone Marrow Mesenchymal Stem Cells. Int. J. Clin. Exp. Med. 2015, 8, 7394–7404. [Google Scholar] [PubMed]
  115. Cheng, Y.; Dai, Y.; Zhu, X.; Xu, H.; Cai, P.; Xia, R.; Mao, L.; Zhao, B.Q.; Fan, W. Extremely Low-Frequency Electromagnetic Fields Enhance the Proliferation and Differentiation of Neural Progenitor Cells Cultured from Ischemic Brains. Neuroreport 2015, 26, 896–902. [Google Scholar] [CrossRef] [PubMed]
  116. Bergandi, L.; Lucia, U.; Grisolia, G.; Salaroglio, I.C.; Gesmundo, I.; Granata, R.; Borchiellini, R.; Ponzetto, A.; Silvagno, F. Thermomagnetic Resonance Effect of the Extremely Low Frequency Electromagnetic Field on Three-Dimensional Cancer Models. Int. J. Mol. Sci. 2022, 23, 7955. [Google Scholar] [CrossRef] [PubMed]
  117. Rezaie-Tavirani, M.; Hasanzadeh, H.; Seyyedi, S.; Zali, H. Proteomic Analysis of the Effect of Extremely Low-Frequency Electromagnetic Fields (ELF-EMF) with Different Intensities in SH-SY5Y Neuroblastoma Cell Line. J. Lasers Med. Sci. 2017, 8, 79–83. [Google Scholar] [CrossRef] [PubMed]
  118. Patruno, A.; Pesce, M.; Grilli, A.; Speranza, L.; Franceschelli, S.; De Lutiis, M.A.; Vianale, G.; Costantini, E.; Amerio, P.; Muraro, R.; et al. MTOR Activation by PI3K/Akt and ERK Signaling in Short ELF-EMF Exposed Human Keratinocytes. PLoS ONE 2015, 10, e0139644. [Google Scholar] [CrossRef] [PubMed]
  119. Oh, I.R.; Raymundo, B.; Jung, S.A.; Kim, H.J.; Park, J.K.; Kim, C.W. Extremely Low-Frequency Electromagnetic Field Altered PPARγ and CCL2 Levels and Suppressed CD44+/CD24− Breast Cancer Cells Characteristics. Bull. Korean Chem. Soc. 2020, 41, 812–823. [Google Scholar] [CrossRef]
  120. Wolf, F.I.; Torsello, A.; Tedesco, B.; Fasanella, S.; Boninsegna, A.; D’Ascenzo, M.; Grassi, C.; Azzena, G.B.; Cittadini, A. 50-Hz Extremely Low Frequency Electromagnetic Fields Enhance Cell Proliferation and DNA Damage: Possible Involvement of a Redox Mechanism. Biochim. Biophys. Acta Mol. Cell Res. 2005, 1743, 120–129. [Google Scholar] [CrossRef] [PubMed]
  121. Ruiz Gómez, M. 25 Hz Electromagnetic Field Exposure Has No Effect on Cell Cycle Distribution and Apoptosis in U-937 and HCA-2/1cch Cells. Bioelectrochemistry 2001, 53, 137–140. [Google Scholar] [CrossRef]
  122. Kim, H.J.; Jung, J.; Park, J.H.; Kim, J.H.; Ko, K.N.; Kim, C.W. Extremely Low-Frequency Electromagnetic Fields Induce Neural Differentiation in Bone Marrow Derived Mesenchymal Stem Cells. Exp. Biol. Med. 2013, 238, 923–931. [Google Scholar] [CrossRef]
  123. Destefanis, M.; Viano, M.; Leo, C.; Gervino, G.; Ponzetto, A.; Silvagno, F. Extremely Low Frequency Electromagnetic Fields Affect Proliferation and Mitochondrial Activity of Human Cancer Cell Lines. Int. J. Radiat. Biol. 2015, 91, 964–972. [Google Scholar] [CrossRef] [PubMed]
  124. Kim, Y.M.; Cho, S.E.; Kim, S.C.; Jang, H.J.; Seo, Y.K. Effects of Extremely Low Frequency Electromagnetic Fields on Melanogenesis through P-ERK and P-SAPK/JNK Pathways in Human Melanocytes. Int. J. Mol. Sci. 2017, 18, 2120. [Google Scholar] [CrossRef] [PubMed]
  125. Srdjenovic, B.; Mrdjanovic, J.; Galovic, A.J.; Kladar, N.; Bozin, B.; Jurisic, V.; Bogdanovic, G. Effect of ELF-EMF on Antioxidant Status and Micronuclei in K562 Cells and Normal Lymphocytes. Cent. Eur. J. Biol. 2014, 9, 931–940. [Google Scholar] [CrossRef]
  126. Huang, C.Y.; Chuang, C.Y.; Shu, W.Y.; Chang, C.W.; Chen, C.R.; Fan, T.C.; Hsu, I.C. Distinct Epidermal Keratinocytes Respond to Extremely Low-Frequency Electromagnetic Fields Differently. PLoS ONE 2014, 9, e113424. [Google Scholar] [CrossRef] [PubMed]
  127. Qiu, L.; Chen, L.; Yang, X.; Ye, A.; Jiang, W.; Sun, W. S1P Mediates Human Amniotic Cells Proliferation Induced by a 50-Hz Magnetic Field Exposure via ERK1/2 Signaling Pathway. J. Cell Physiol. 2019, 234, 7734–7741. [Google Scholar] [CrossRef] [PubMed]
  128. Chen, L.; Xia, Y.; Lu, J.; Xie, Q.; Ye, A.; Sun, W. A 50-Hz Magnetic-Field Exposure Promotes Human Amniotic Cells Proliferation via SphK–S1P–S1PR Cascade Mediated ERK Signaling Pathway. Ecotoxicol. Environ. Saf. 2020, 194, 110407. [Google Scholar] [CrossRef]
  129. Ding, Z.; Li, J.; Li, F.; Mephryar, M.M.; Wu, S.; Zhang, C.; Zeng, Y. Vitamin C and Vitamin E Protected B95-8 and Balb/c-3T3 Cells from Apoptosis Induced by Intermittent 50 Hz ELF-EMF Radiation. Iran. J. Public Health 2017, 46, 23–34. [Google Scholar] [PubMed]
  130. Ramazi, S.; Salimian, M.; Allahverdi, A.; Kianamiri, S.; Abdolmaleki, P. Synergistic Cytotoxic Effects of an Extremely Low-Frequency Electromagnetic Field with Doxorubicin on MCF-7 Cell Line. Sci. Rep. 2023, 13, 8844. [Google Scholar] [CrossRef] [PubMed]
  131. Iorio, R.; Delle Monache, S.; Bennato, F.; Di Bartolomeo, C.; Scrimaglio, R.; Cinque, B.; Colonna, R.C. Involvement of Mitochondrial Activity in Mediating ELF-EMF Stimulatory Effect on Human Sperm Motility. Bioelectromagnetics 2011, 32, 15–27. [Google Scholar] [CrossRef]
  132. Patruno, A.; Amerio, P.; Pesce, M.; Vianale, G.; Di Luzio, S.; Tulli, A.; Franceschelli, S.; Grilli, A.; Muraro, R.; Reale, M. Extremely Low Frequency Electromagnetic Fields Modulate Expression of Inducible Nitric Oxide Synthase, Endothelial Nitric Oxide Synthase and Cyclooxygenase-2 in the Human Keratinocyte Cell Line HaCat: Potential Therapeutic Effects in Wound Healing. Br. J. Dermatol. 2010, 162, 258–266. [Google Scholar] [CrossRef]
  133. Frahm, J.; Lantow, M.; Lupke, M.; Weiss, D.G.; Simkó, M. Alteration in Cellular Functions in Mouse Macrophages after Exposure to 50 Hz Magnetic Fields. J. Cell Biochem. 2006, 99, 168–177. [Google Scholar] [CrossRef] [PubMed]
  134. Kim, S.J.; Jang, Y.W.; Hyung, K.E.; Lee, D.K.; Hyun, K.H.; Jeong, S.H.; Min, K.H.; Kang, W.; Jeong, J.H.; Park, S.Y.; et al. Extremely Low-Frequency Electromagnetic Field Exposure Enhances Inflammatory Response and Inhibits Effect of Antioxidant in RAW 264.7 Cells. Bioelectromagnetics 2017, 38, 374–385. [Google Scholar] [CrossRef] [PubMed]
  135. Patruno, A.; Costantini, E.; Ferrone, A.; Pesce, M.; Francesca, D.; Trubiani, O.; Reale, M. Short ELF-EMF Exposure Targets SIRT1/NRF2/HO-1 Signaling in THP-1 Cells. Int. J. Mol. Sci. 2020, 21, 7284. [Google Scholar] [CrossRef] [PubMed]
  136. Buldak, R.J.; Polaniak, R.; Buldak, L.; Zwirska-Korczala, K.; Skonieczna, M.; Monsiol, A.; Kukla, M.; Dulawa-Buldak, A.; Birkner, E. Short-Term Exposure to 50Hz ELF-EMF Alters the Cisplatin-Induced Oxidative Response in AT478 Murine Squamous Cell Carcinoma Cells. Bioelectromagnetics 2012, 33, 641–651. [Google Scholar] [CrossRef] [PubMed]
  137. Huang, C.Y.; Chang, C.W.; Chen, C.R.; Chuang, C.Y.; Chiang, C.S.; Shu, W.Y.; Fan, T.C.; Hsu, I.C. Extremely Low-Frequency Electromagnetic Fields Cause G1 Phase Arrest through the Activation of the ATM-Chk2-P21 Pathway. PLoS ONE 2014, 9, e104732. [Google Scholar] [CrossRef]
  138. Mihai, C.T.; Rotinberg, P.; Brinza, F.; Vochita, G. Extremely Low-Frequency Electromagnetic Fields Cause DNA Strand Breaks in Normal Cells. J. Environ. Health Sci. Eng. 2014, 12, 15. [Google Scholar] [CrossRef] [PubMed]
  139. National Radiological Protection Board (NRPB). Advice on Limiting Exposure to Electromagnetic Fields (0–300 GHz). In Documents of the NRPB; 2004; Volume 15, pp. 1–35. ISBN 978-0-85951-532-0. Available online: https://www.emf-portal.org/en/article/10656 (accessed on 1 May 2024).
  140. National Radiological Protection Board (NRPB). Review of the Scientific Evidence for Limiting Exposure to Electromagnetic Fields (0–300 GHz); 2004; Volume 15, ISBN 978-0-85951-533-7. Available online: https://www.emf-portal.org/en/article/10657 (accessed on 1 May 2024).
  141. Scientific Committee on Emerging Newly Identified Health Risks. Opinion on potential health effects of exposure to electromagnetic fields. Bioelectromagnetics 2015, 36, 480–484. [Google Scholar] [CrossRef] [PubMed]
  142. Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR). Health Effects of Exposure to EMF; 2009; Available online: https://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_022.pdf (accessed on 1 May 2024).
  143. Kaczmarek, L.K.; Adey, W.R. The Efflux Of 45Ca2+ and [3H]γ-Aminobutyric Acid from Cat Cerebral Cortex. Brain Res. 1973, 63, 331–342. [Google Scholar] [CrossRef] [PubMed]
  144. Bernardi, P.; D’Inzeo, G. Analysis of the Interaction between Microwave Fields and Snail Neurons by an Ionic Model of the Membrane Electrical Activity. Alta. Freq. 1989, 4, 341–347. [Google Scholar]
  145. Adair, R.K. Criticism of Lednev’s Mechanism for the Influence of Weak Magnetic Fields on Biological Systems. Bioelectromagnetics 1992, 13, 231–235. [Google Scholar] [CrossRef]
  146. Parkinson, W.C.; Hanks, C.T. Search for Cyclotron Resonance in Cells in Vitro. Bioelectromagnetics 1989, 10, 129–145. [Google Scholar] [CrossRef] [PubMed]
  147. Liboff, A.R.; McLeod, B.R. Kinetics of Channelized Membrane Ions in Magnetic Fields. Bioelectromagnetics 1988, 9, 39–51. [Google Scholar] [CrossRef] [PubMed]
  148. Smith, S.D.; McLeod, B.R.; Liboff, A.R.; Cooksey, K. Calcium Cyclotron Resonance and Diatom Mobility. Bioelectromagnetics 1987, 8, 215–227. [Google Scholar] [CrossRef] [PubMed]
  149. Blackman, C.F.; Blanchard, J.P.; Benane, S.G.; House, D.E. Empirical Test of an Ion Parametric Resonance Model for Magnetic Field Interactions with PC-12 Cells. Bioelectromagnetics 1994, 15, 239–260. [Google Scholar] [CrossRef] [PubMed]
  150. Blanchard, J.P.; Blackman, C.F. Clarification and Application of an Ion Parametric Resonance Model for Magnetic Field Interactions with Biological Systems. Bioelectromagnetics 1994, 15, 217–238. [Google Scholar] [CrossRef] [PubMed]
  151. Azanza, M.J.; del Moral, A.; Pérez Bruzón, R.N. Frequency Resonance Effect of Neurons under Low-Frequency Weak Magnetic Field. J. Magn. Magn. Mater. 2007, 310, 2865–2867. [Google Scholar] [CrossRef]
  152. Blackman, C.F.; Blanchard, J.P.; Benane, S.G.; House, D.E. Experimental Determination of Hydrogen Bandwidth for the Ion Parametric Resonance Model. Bioelectromagnetics 1999, 20, 5–12. [Google Scholar] [CrossRef]
  153. Markov, M. Dosimetry in Bioelectromagnetics. In Dosimetry in Bioelectromagnetics; Markov, M., Ed.; Taylor & Francis: New York, NY, USA, 2017; pp. 1–23. ISBN 978-1-4987-7413-0. [Google Scholar]
  154. Adair, R.K. Effects of Very Weak Magnetic Fields on Radical Pair Reformation. Bioelectromagnetics 1999, 20, 255–263. [Google Scholar] [CrossRef]
  155. Barnes, F.S.; Greenebaum, B. The Effects of Weak Magnetic Fields on Radical Pairs. Bioelectromagnetics 2015, 36, 45–54. [Google Scholar] [CrossRef]
  156. Wang, K.; Ritz, T. Zeeman Resonances for Radical-Pair Reactions in Weak Static Magnetic Fields. Mol. Phys. 2006, 104, 1649–1658. [Google Scholar] [CrossRef]
Figure 1. Identification diagram of databases and records following PRISMA-ScR protocol.
Figure 1. Identification diagram of databases and records following PRISMA-ScR protocol.
Ijms 25 05074 g001
Figure 2. Diagrams representing items excluded and included in the review. (A) Total number of items in PubMed and Scopus according to search criteria. (B) Reason for exclusion of articles is not included (duplicate articles are not represented).
Figure 2. Diagrams representing items excluded and included in the review. (A) Total number of items in PubMed and Scopus according to search criteria. (B) Reason for exclusion of articles is not included (duplicate articles are not represented).
Ijms 25 05074 g002
Figure 3. The temporal distribution of the articles included in the review by the year of publication.
Figure 3. The temporal distribution of the articles included in the review by the year of publication.
Ijms 25 05074 g003
Figure 4. (A) The distribution of the cellular process studied over the total number of experiments analysed (n = 531). (B) The distribution of tumour (T)/non-tumour (NT) cells according to the cell process studied (V: viability, PR: proliferation, A: apoptosis, OS: oxidative stress/mitochondria, CC: cell cycle).
Figure 4. (A) The distribution of the cellular process studied over the total number of experiments analysed (n = 531). (B) The distribution of tumour (T)/non-tumour (NT) cells according to the cell process studied (V: viability, PR: proliferation, A: apoptosis, OS: oxidative stress/mitochondria, CC: cell cycle).
Ijms 25 05074 g004
Figure 5. Bar charts of percentage of experiments with significant increase (green) and decrease (red), and non-significant (blue) results, differentiated by cell process ((A) viability, (B) proliferation, (C) apoptosis, (D) oxidative stress, (E) cell cycle) and cell type (T: tumour, NT: non-tumour).
Figure 5. Bar charts of percentage of experiments with significant increase (green) and decrease (red), and non-significant (blue) results, differentiated by cell process ((A) viability, (B) proliferation, (C) apoptosis, (D) oxidative stress, (E) cell cycle) and cell type (T: tumour, NT: non-tumour).
Ijms 25 05074 g005
Figure 6. A bar chart of the percentage of experiments performed for each division of the different exposure parameters set: frequency (A), intensity (B), exposure time (C) and exposure mode (D) (I: intermittent; C: continuous).
Figure 6. A bar chart of the percentage of experiments performed for each division of the different exposure parameters set: frequency (A), intensity (B), exposure time (C) and exposure mode (D) (I: intermittent; C: continuous).
Ijms 25 05074 g006
Figure 7. Bar charts of the occurrence of non-significant (blue), increase (green), decrease (red) results according to frequency bands in tumour and non-tumour cells in viability. (A,B) Frequencies below and above 50 Hz; (C,D) frequencies between 0 and 100 Hz in 20 Hz steps.
Figure 7. Bar charts of the occurrence of non-significant (blue), increase (green), decrease (red) results according to frequency bands in tumour and non-tumour cells in viability. (A,B) Frequencies below and above 50 Hz; (C,D) frequencies between 0 and 100 Hz in 20 Hz steps.
Ijms 25 05074 g007
Figure 8. Bar graphs of the occurrence of non-significant (blue), increase (green), decrease (red) results according to frequency bands in tumour and non-tumour cells in different cellular processes ((A,B) proliferation; (C,D) apoptosis; (E,F) oxidative stress). Bar graphs of the occurrence of non-significant (blue) and significant (green) results according to frequency bands in tumour and non-tumour cells in cell cycle (G,H)).
Figure 8. Bar graphs of the occurrence of non-significant (blue), increase (green), decrease (red) results according to frequency bands in tumour and non-tumour cells in different cellular processes ((A,B) proliferation; (C,D) apoptosis; (E,F) oxidative stress). Bar graphs of the occurrence of non-significant (blue) and significant (green) results according to frequency bands in tumour and non-tumour cells in cell cycle (G,H)).
Ijms 25 05074 g008
Figure 9. Bar charts of the occurrence of non-significant (blue), increase (green), decrease (red) results according to intensity bands in tumour and non-tumour cells in different cellular processes ((A,B) viability; (C,D) proliferation; (E,F) apoptosis; (G,H) oxidative stress. Bar graphs of the occurrence of non-significant (blue) and significant (green) results according to frequency bands in tumour and non-tumour cells in cell cycle (I,J)).
Figure 9. Bar charts of the occurrence of non-significant (blue), increase (green), decrease (red) results according to intensity bands in tumour and non-tumour cells in different cellular processes ((A,B) viability; (C,D) proliferation; (E,F) apoptosis; (G,H) oxidative stress. Bar graphs of the occurrence of non-significant (blue) and significant (green) results according to frequency bands in tumour and non-tumour cells in cell cycle (I,J)).
Ijms 25 05074 g009
Figure 10. Bar charts of the occurrence of non-significant (blue), increase (green), decrease (red) results according to exposure time bands in tumour and non-tumour cells in different cellular processes ((A,B) viability; (C,D) proliferation; (E,F) apoptosis; (G,H) oxidative stress. Bar graphs of the occurrence of non-significant (blue) and significant (green) results according to frequency bands in tumour and non-tumour cells in cell cycle (I,J)).
Figure 10. Bar charts of the occurrence of non-significant (blue), increase (green), decrease (red) results according to exposure time bands in tumour and non-tumour cells in different cellular processes ((A,B) viability; (C,D) proliferation; (E,F) apoptosis; (G,H) oxidative stress. Bar graphs of the occurrence of non-significant (blue) and significant (green) results according to frequency bands in tumour and non-tumour cells in cell cycle (I,J)).
Ijms 25 05074 g010
Figure 11. Bar charts of the occurrence of non-significant (blue), increase (green), decrease (red) results according to exposure mode (C: continuous/I: intermittent) in tumour and non-tumour cells in different cellular processes ((A) viability; (B) proliferation; (C) apoptosis; (D) oxidative stress. Bar graphs of the occurrence of non-significant (blue) and significant (green) results according to frequency bands in tumour and non-tumour cells in cell cycle (E)).
Figure 11. Bar charts of the occurrence of non-significant (blue), increase (green), decrease (red) results according to exposure mode (C: continuous/I: intermittent) in tumour and non-tumour cells in different cellular processes ((A) viability; (B) proliferation; (C) apoptosis; (D) oxidative stress. Bar graphs of the occurrence of non-significant (blue) and significant (green) results according to frequency bands in tumour and non-tumour cells in cell cycle (E)).
Ijms 25 05074 g011
Table 1. A table containing the individual experiments of the articles selected according to the inclusion criteria for the analysis of the viability results in continuous exposure mode. Results: non-significant (0); decrease (1); increase (2). Increasing order by frequency.
Table 1. A table containing the individual experiments of the articles selected according to the inclusion criteria for the analysis of the viability results in continuous exposure mode. Results: non-significant (0); decrease (1); increase (2). Increasing order by frequency.
IDAuthorsFrequency (Hz)Intensity (mT)Exposure Time (h)Cell Type (T/NT)ResultsIDAuthorsFrequency (Hz)Intensity (mT)Exposure Time (h)Cell Type (T/NT)Results
1Nezamtaheri et al. (2022) [74]0.01102T0133Koziorowska, A. et al. (2018) [75]5020.5T1
2Nezamtaheri et al. (2022) [74]0.01102NT0134Koziorowska, A. et al. (2018) [75]5020.5T1
3Nezamtaheri et al. (2022) [74]0.01102T0135Koziorowska, A. et al. (2018) [75]5020.5NT2
4Nezamtaheri et al. (2022) [74]0.01102T0136Koziorowska, A. et al. (2018) [75]5020.5NT2
5Koziorowska, A. et al. (2018) [75]222T1137Koziorowska, A. et al. (2018) [75]5021T1
6Ledda et al. (2018) [76]70.0125120T2138Koziorowska, A. et al. (2018) [75]5021T1
7Ledda et al. (2018) [76]70.0125120T2139Koziorowska, A. et al. (2018) [75]5021NT2
8García-Minguillán, O. et al. (2019) [77]7.80.0324NT0140Koziorowska, A. et al. (2018) [75]5021NT2
9García-Minguillán, O. et al. (2019) [77]7.80.0324NT0141Koziorowska, A. et al. (2018) [75]5022T1
10García-Minguillán, O. et al. (2019) [77]140.0324T0142Koziorowska, A. et al. (2018) [75]5022T1
11García-Minguillán, O. et al. (2020) [78]200.0324T1143Koziorowska, A. et al. (2018) [75]5022NT2
12García-Minguillán, O. et al. (2020) [78]200.124T0144Koziorowska, A. et al. (2018) [75]5022NT0
13García-Minguillán, O. et al. (2020) [78]200.148T2145Koziorowska, A. et al. (2018) [75]5023T1
14García-Minguillán, O. et al. (2020) [78]200.172T0146Koziorowska, A. et al. (2018) [75]5023T1
15Koziorowska, A. et al. (2018) [75]2022T1147Koziorowska, A. et al. (2018) [75]5023NT2
16Koziorowska, A. et al. (2018) [75]2022T0148Koziorowska, A. et al. (2018) [75]5023NT0
17Koziorowska, A. et al. (2018) [75]2022NT2149Koziorowska, A. et al. (2018) [75]502.50.5T0
18Koziorowska, A. et al. (2018) [75]2022NT0150Koziorowska, A. et al. (2018) [75]502.50.5T1
19Koziorowska, A. et al. (2018) [75]202.52T1151Koziorowska, A. et al. (2018) [75]502.50.5NT2
20Koziorowska, A. et al. (2018) [75]202.52T0152Koziorowska, A. et al. (2018) [75]502.50.5NT2
21Koziorowska, A. et al. (2018) [75]202.52NT2153Koziorowska, A. et al. (2018) [75]502.51T1
22Koziorowska, A. et al. (2018) [75]202.52NT0154Koziorowska, A. et al. (2018) [75]502.51T1
23Koziorowska, A. et al. (2018) [75]2032T0155Koziorowska, A. et al. (2018) [75]502.51NT2
24Koziorowska, A. et al. (2018) [75]2032T0156Koziorowska, A. et al. (2018) [75]502.51NT2
25Koziorowska, A. et al. (2018) [75]2032NT2157Koziorowska, A. et al. (2018) [75]502.52T1
26Koziorowska, A. et al. (2018) [75]2032NT0158Koziorowska, A. et al. (2018) [75]502.52T1
27Koziorowska, A. et al. (2018) [75]2042T0159Koziorowska, A. et al. (2018) [75]502.52NT2
28Koziorowska, A. et al. (2018) [75]2042T0160Koziorowska, A. et al. (2018) [75]502.52NT0
29Koziorowska, A. et al. (2018) [75]2042NT2161Koziorowska, A. et al. (2018) [75]502.53T1
30Koziorowska, A. et al. (2018) [75]2042NT0162Koziorowska, A. et al. (2018) [75]502.53T1
31Koziorowska, A. et al. (2018) [75]2062T0163Koziorowska, A. et al. (2018) [75]502.53NT2
32Koziorowska, A. et al. (2018) [75]2062T1164Koziorowska, A. et al. (2018) [75]502.53NT2
33Koziorowska, A. et al. (2018) [75]2062NT2165Koziorowska, A. et al. (2018) [75]5030.5T0
34Koziorowska, A. et al. (2018) [75]2062NT0166Koziorowska, A. et al. (2018) [75]5030.5T1
35Wang, M. et al. (2021) [79]23.490.548T1167Koziorowska, A. et al. (2018) [75]5030.5NT2
36Wang, M. et al. (2021) [79]23.490.548T1168Koziorowska, A. et al. (2018) [75]5030.5NT2
37Wang, M. et al. (2021) [79]23.490.548NT2169Koziorowska, A. et al. (2018) [75]5031T1
38García-Minguillán, O. et al. (2020) [78]300.124T1170Koziorowska, A. et al. (2018) [75]5031T1
39García-Minguillán, O. et al. (2020) [78]300.148T1171Koziorowska, A. et al. (2018) [75]5031NT2
40García-Minguillán, O. et al. (2020) [78]300.172T1172Koziorowska, A. et al. (2018) [75]5031NT2
41Koziorowska, A. et al. (2018) [75]3022T1173Koziorowska, A. et al. (2018) [75]5032T1
42Koziorowska, A. et al. (2018) [75]3022T1174Koziorowska, A. et al. (2018) [75]5032T1
43Koziorowska, A. et al. (2018) [75]3022NT0175Koziorowska, A. et al. (2018) [75]5032NT2
44Koziorowska, A. et al. (2018) [75]3022NT2176Koziorowska, A. et al. (2018) [75]5032NT2
45Koziorowska, A. et al. (2018) [75]302.52T1177Koziorowska, A. et al. (2018) [75]5033T1
46Koziorowska, A. et al. (2018) [75]302.52T1178Koziorowska, A. et al. (2018) [75]5033T1
47Koziorowska, A. et al. (2018) [75]302.52NT2179Koziorowska, A. et al. (2018) [75]5033NT2
48Koziorowska, A. et al. (2018) [75]302.52NT2180Koziorowska, A. et al. (2018) [75]5033NT0
49Koziorowska, A. et al. (2018) [75]3032T1181Koziorowska, A. et al. (2018) [75]5040.5T0
50Koziorowska, A. et al. (2018) [75]3032T1182Koziorowska, A. et al. (2018) [75]5040.5T1
51Koziorowska, A. et al. (2018) [75]3032NT2183Koziorowska, A. et al. (2018) [75]5040.5NT2
52Koziorowska, A. et al. (2018) [75]3032NT2184Koziorowska, A. et al. (2018) [75]5040.5NT2
53Koziorowska, A. et al. (2018) [75]3042T1185Koziorowska, A. et al. (2018) [75]5041T1
54Koziorowska, A. et al. (2018) [75]3042T1186Koziorowska, A. et al. (2018) [75]5041T1
55Koziorowska, A. et al. (2018) [75]3042NT0187Koziorowska, A. et al. (2018) [75]5041NT2
56Koziorowska, A. et al. (2018) [75]3042NT2188Koziorowska, A. et al. (2018) [75]5041NT2
57Koziorowska, A. et al. (2018) [75]3062T0189Koziorowska, A. et al. (2018) [75]5042T1
58Koziorowska, A. et al. (2018) [75]3062T1190Koziorowska, A. et al. (2018) [75]5042T1
59Koziorowska, A. et al. (2018) [75]3062NT0191Koziorowska, A. et al. (2018) [75]5042NT2
60Koziorowska, A. et al. (2018) [75]3062NT0192Koziorowska, A. et al. (2018) [75]5042NT0
61Wang, M. et al. (2021) [79]39.150.548T0193Koziorowska, A. et al. (2018) [75]5043T1
62Wang, M. et al. (2021) [79]39.150.548T2194Koziorowska, A. et al. (2018) [75]5043T1
63Wang, M. et al. (2021) [79]39.150.548NT2195Koziorowska, A. et al. (2018) [75]5043NT2
64Koziorowska, A. et al. (2018) [75]4022T1196Koziorowska, A. et al. (2018) [75]5043NT2
65Koziorowska, A. et al. (2018) [75]4022T1197Koziorowska, A. et al. (2018) [75]5060.5T0
66Koziorowska, A. et al. (2018) [75]4022NT2198Koziorowska, A. et al. (2018) [75]5060.5T1
67Koziorowska, A. et al. (2018) [75]4022NT0199Koziorowska, A. et al. (2018) [75]5060.5NT2
68Koziorowska, A. et al. (2018) [75]402.52T0200Koziorowska, A. et al. (2018) [75]5060.5NT2
69Koziorowska, A. et al. (2018) [75]402.52T1201Koziorowska, A. et al. (2018) [75]5061T1
70Koziorowska, A. et al. (2018) [75]402.52NT2202Koziorowska, A. et al. (2018) [75]5061T1
71Koziorowska, A. et al. (2018) [75]402.52NT0203Koziorowska, A. et al. (2018) [75]5061NT2
72Koziorowska, A. et al. (2018) [75]4032T0204Koziorowska, A. et al. (2018) [75]5061NT2
73Koziorowska, A. et al. (2018) [75]4032T1205Koziorowska, A. et al. (2018) [75]5062T1
74Koziorowska, A. et al. (2018) [75]4032NT2206Koziorowska, A. et al. (2018) [75]5062T1
75Koziorowska, A. et al. (2018) [75]4032NT0207Koziorowska, A. et al. (2018) [75]5062NT2
76Koziorowska, A. et al. (2018) [75]4042T0208Koziorowska, A. et al. (2018) [75]5062NT0
77Koziorowska, A. et al. (2018) [75]4042T1209Koziorowska, A. et al. (2018) [75]5063T0
78Koziorowska, A. et al. (2018) [75]4042NT2210Koziorowska, A. et al. (2018) [75]5063T1
79Koziorowska, A. et al. (2018) [75]4042NT0211Koziorowska, A. et al. (2018) [75]5063NT0
80Koziorowska, A. et al. (2018) [75]4062T0212Koziorowska, A. et al. (2018) [75]5063NT0
81Koziorowska, A. et al. (2018) [75]4062T1213Yin, C. et al. (2016) [80]5081.5NT1
82Koziorowska, A. et al. (2018) [75]4062NT2214García-Minguillán, O. et al. (2019) [77]510.0324T1
83Koziorowska, A. et al. (2018) [75]4062NT0215Cho, S. et al. (2014) [81]600.824NT0
84García-Minguillán, O. et al. (2019) [77]450.0324T1216Cho, S. et al. (2014) [81]600.848NT0
85De Groot, M. et al. (2016) [82]500.001168NT0217Koziorowska, A. et al. (2018) [75]6022T0
86De Groot, M. et al. (2016) [82]500.01168NT0218Koziorowska, A. et al. (2018) [75]6022T0
87Calcabrini, C. et al. (2017) [83]500.0251NT0219Koziorowska, A. et al. (2018) [75]6022NT2
88Calcabrini, C. et al. (2017) [83]500.051NT0220Koziorowska, A. et al. (2018) [75]6022NT2
89Calcabrini, C. et al. (2017) [83]500.11NT0221Koziorowska, A. et al. (2018) [75]602.52T0
90De Groot, M. et al. (2016) [82]500.1168NT0222Koziorowska, A. et al. (2018) [75]602.52T0
91García-Minguillán, O. et al. (2020) [78]500.124T1223Koziorowska, A. et al. (2018) [75]602.52NT2
92García-Minguillán, O. et al. (2020) [78]500.148T0224Koziorowska, A. et al. (2018) [75]602.52NT2
93García-Minguillán, O. et al. (2020) [78]500.172T2225Koziorowska, A. et al. (2018) [75]6032T0
94Morabito, C. et al. (2017) [84]500.1168NT0226Koziorowska, A. et al. (2018) [75]6032T0
95Calcabrini, C. et al. (2017) [83]500.21NT0227Koziorowska, A. et al. (2018) [75]6032NT2
96Morabito, C. et al. (2017) [84]500.5168NT0228Koziorowska, A. et al. (2018) [75]6032NT2
97Ma, Q. et al. (2014) [85]500.572NT0229Koziorowska, A. et al. (2018) [75]6042T0
98Ma, Q. et al. (2014) [85]50172NT0230Koziorowska, A. et al. (2018) [75]6042T0
99Costantini, E. et al. (2022) [86]5016NT2231Koziorowska, A. et al. (2018) [75]6042NT2
100Costantini, E. et al. (2022) [86]50124NT2232Koziorowska, A. et al. (2018) [75]6042NT2
101Costantini, E. et al. (2022) [86]50148NT2233Koziorowska, A. et al. (2018) [75]6062T0
102Morabito, C. et al. (2017) [84]501168NT0234Koziorowska, A. et al. (2018) [75]6062T0
103De Groot, M. et al. (2016) [82]501168NT0235Koziorowska, A. et al. (2018) [75]6062NT2
104Duan, W. et al. (2015) [87]50124NT0236Koziorowska, A. et al. (2018) [75]6062NT2
105Park, J. et al. (2013) [88]50196NT0237Song, K. et al. (2018) [89]6060.5T0
106Park, J. et al. (2013) [88]501192NT0238Song, K. et al. (2018) [89]6060.5T0
107Garip, A. et al. (2010) [90]5013T0239Song, K. et al. (2018) [89]6062.5T0
108Vianale, G. et al. (2008) [91]5014NT0240Song, K. et al. (2018) [89]6062.5T0
109Vianale, G. et al. (2008) [91]50112NT0241Song, K. et al. (2018) [89]60624T0
110Vianale, G. et al. (2008) [91]50124NT0242Song, K. et al. (2018) [89]60624T0
111Vianale, G. et al. (2008) [91]50148NT0243Song, K. et al. (2018) [89]60648T1
112Vianale, G. et al. (2008) [91]50172NT0244Song, K. et al. (2018) [89]60648T1
113Vianale, G. et al. (2008) [91]50196NT0245Song, K. et al. (2018) [89]60672T1
114Morabito, C. et al. (2010) [92]5010.5T0246Song, K. et al. (2018) [89]60672T1
115Morabito, C. et al. (2010) [92]50124T0247Song, K. et al. (2018) [89]60696T0
116Morabito, C. et al. (2010) [92]50148T0248Song, K. et al. (2018) [89]60696T0
117Morabito, C. et al. (2010) [92]50172T0249Song, K. et al. (2018) [89]60696T0
118Morabito, C. et al. (2010) [92]50196T0250Song, K. et al. (2018) [89]606120T0
119Morabito, C. et al. (2010) [92]501144T0251Song, K. et al. (2018) [89]606120T1
120Morabito, C. et al. (2010) [92]501192T0252Song, K. et al. (2018) [89]606144T1
121Reale, M. et al. (2014) [93]5011T0253Song, K. et al. (2018) [89]606144T1
122Reale, M. et al. (2014) [93]5013T0254Song, K. et al. (2018) [89]606144T1
123Reale, M. et al. (2014) [93]5016T0255Song, K. et al. (2018) [89]606168T1
124Reale, M. et al. (2014) [93]50124T0256Song, K. et al. (2018) [89]606168T1
125Falone, S. et al. (2007) [94]50124T0257Akbarnejad, Z. et al. (2017) [95]1001072T0
126Falone, S. et al. (2007) [94]50148T0258Akbarnejad, Z. et al. (2017) [95]1001072T0
127Falone, S. et al. (2007) [94]50172T2259Akbarnejad, Z. et al. (2017) [95]1001096T1
128Falone, S. et al. (2007) [94]50196T2260Akbarnejad, Z. et al. (2017) [95]1001096T1
129Ma, Q. et al. (2014) [85]50224NT0261Akbarnejad, Z. et al. (2017) [95]10010120T1
130Ma, Q. et al. (2014) [85]50248NT0262Akbarnejad, Z. et al. (2017) [95]10010120T1
131Ma, Q. et al. (2014) [85]50272NT0263Akbarnejad, Z. et al. (2017) [95]10010144T1
132Barati, A. et al. (2023) [96]50272T1264Akbarnejad, Z. et al. (2017) [95]10010144T1
Table 2. A table containing the individual experiments of the articles selected according to the inclusion criteria for the analysis of the intermittent exposure mode. Results: non-significant (0); decrease (1); increase (2).
Table 2. A table containing the individual experiments of the articles selected according to the inclusion criteria for the analysis of the intermittent exposure mode. Results: non-significant (0); decrease (1); increase (2).
IDAuthorsCell Type (T/NT)ResultsIDAuthorsCell Type (T/NT)Results
VIABILITY 27Rahimi, S. et al. (2023) [97]NT0
1Wang, M. et al. (2021) [79]T028Razavi, S. et al. (2013) [98]NT2
2Wang, M. et al. (2021) [79]T129Razavi, S. et al. (2013) [98]NT2
3Wang, M. et al. (2021) [79]NT030Razavi, S. et al. (2013) [98]NT2
4Wang, M. et al. (2021) [79]T031Razavi, S. et al. (2013) [98]NT0
5Wang, M. et al. (2021) [79]T132Focke, F. et al. (2010) [99]NT1
6Wang, M. et al. (2021) [79]NT033Focke, F. et al. (2010) [99]T0
7Wang, M. et al. (2021) [79]T034Grant, D. et al. (2014) [100]NT0
8Wang, M. et al. (2021) [79]T1APOPTOSIS
9Wang, M. et al. (2021) [79]NT21Cios, A. et al. (2021) [101]NT0
10Ross, C. et al. (2018) [102]NT02Cios, A. et al. (2021) [101]T2
11García-Minguillán, O. et al. (2019) [77]T03Cios, A. et al. (2021) [101]NT0
12García-Minguillán, O. et al. (2019) [77]T14Cios, A. et al. (2021) [101]T0
13Barati, A. et al. (2021) [96]T15Liu, Y. et al. (2015) [103]NT0
14Samiei, M. et al. (2020) [104]NT26Liu, Y. et al. (2015) [103]NT0
15Samiei, M. et al. (2020) [104]NT27Liu, Y. et al. (2015) [103]NT0
16Samiei, M. et al. (2020) [104]NT28Ma, Q. et al. (2016) [105]NT0
17Samiei, M. et al. (2020) [104]NT09Focke, F. et al. (2010) [99]NT2
18Cios, A. et al. (2021) [101]NT210Focke, F. et al. (2010) [99]T0
19Cios, A. et al. (2021) [101]T1OXIDATIVE STRESS/MITOCHONDRIA
20Cios, A. et al. (2021) [101]NT11Cios, A. et al. (2021) [101]NT2
21Cios, A. et al. (2021) [101]T12Cios, A. et al. (2021) [101]T2
PROLIFERATION 3Cios, A. et al. (2021) [101]NT2
1Mehdizadeh, R. et al. (2023) [106] 14Cios, A. et al. (2021) [101]T2
2Mehdizadeh, R. et al. (2023) [106]T05Lekovic, M. et al. (2020) [107]NT1
3Mehdizadeh, R. et al. (2023) [106]T16Lekovic, M. et al. (2020) [107]NT0
4Ross, C. et al. (2018) [102]T07Lekovic, M. et al. (2020) [107]NT1
5Ross, C. et al. (2018) [102]NT08Lekovic, M. et al. (2020) [107]NT2
6Fathi, E. et al. (2017) [108]NT19Ayse, I. et al. (2010) [109]T2
7Lekovic, M. et al. (2020) [107]NT010Choi, J. et al. (2022) [110]NT2
8Lekovic, M. et al. (2020) [107]NT211Choi, J. et al. (2022) [110]NT2
9Lekovic, M. et al. (2020) [107]NT012Choi, J. et al. (2022) [110]NT2
10Lekovic, M. et al. (2020) [107]NT113Choi, J. et al. (2022) [110]NT2
11Ma, Q. et al. (2016) [105]NT014Choi, J. et al. (2022) [110]NT2
12Ma, Q. et al. (2016) [105]NT015Choi, J. et al. (2022) [110]NT2
13Ma, Q. et al. (2016) [105]NT216Ki, G. et al. (2020) [111]NT2
14Restrepo, A.F. et al. (2016) [112]NT017Falone, S. et al. (2016) [113]T2
15Restrepo, A.F. et al. (2016) [112]NT2CELL CYCLE
16Restrepo, A.F. et al. (2016) [112]NT21Cios, A. et al. (2021) [101]NT0
17Restrepo, A.F. et al. (2016) [112]NT22Cios, A. et al. (2021) [101]T1
18Restrepo, A.F. et al. (2016) [112]NT23Cios, A. et al. (2021) [101]NT1
19Restrepo, A.F. et al. (2016) [112]NT24Cios, A. et al. (2021) [101]T1
20Restrepo, A.F. et al. (2016) [112]NT25Fan, W. et al. (2015) [114]NT1
21Restrepo, A.F. et al. (2016) [112]NT26Liu, Y. et al. (2015) [103]NT0
22Restrepo, A.F. et al. (2016) [112]NT27Liu, Y. et al. (2015) [103]NT0
23Restrepo, A.F. et al. (2016) [112]NT28Liu, Y. et al. (2015) [103]NT0
24Rahimi, S. et al. (2023) [97]NT29Focke, F. et al. (2010) [99]NT0
25Rahimi, S. et al. (2023) [97]NT110Focke, F. et al. (2010) [99]T0
26Rahimi, S. et al. (2023) [97]NT1
Table 3. A table containing the individual experiments of the articles selected according to the inclusion criteria for the analysis of the proliferation results in continuous exposure mode. Results: non-significant (0); decrease (1); increase (2). Increasing order by frequency.
Table 3. A table containing the individual experiments of the articles selected according to the inclusion criteria for the analysis of the proliferation results in continuous exposure mode. Results: non-significant (0); decrease (1); increase (2). Increasing order by frequency.
IDAuthorsFrequency (Hz)Intensity (mT)Exposure Time (h)Cell Type (T/NT)ResultsIDAuthorsFrequency (Hz)Intensity (mT)Exposure Time (h)Cell Type (T/NT)Results
1Nezamtaheri, M. et al. (2022) [74]0.0112T143Cheng, Y. et al. (2015) [115]500.44NT0
2Nezamtaheri, M. et al. (2022) [74]0.011120T144Cheng, Y. et al. (2015) [115]500.48NT0
3Nezamtaheri, M. et al. (2022) [74]0.011120NT145Cheng, Y. et al. (2015) [115]500.416NT2
4Nezamtaheri, M. et al. (2022) [74]0.011120T146Cheng, Y. et al. (2015) [115]500.424NT2
5Nezamtaheri, M. et al. (2022) [74]10.1120T147Cheng, Y. et al. (2015) [115]500.432NT2
6Bergandi, L. et al. (2022) [116]30.11548T148Rezaie-Tavirani, M. et al. (2017) [117]500.53T1
7Bergandi, L. et al. (2022) [116]40.11548T149Morabito, C. et al. (2017) [84]500.5168NT0
8Bergandi, L. et al. (2022) [116]60.11548T150Patruno, A. et al. (2015) [118]5011NT2
9Bergandi, L. et al. (2022) [116]60.11548T051Patruno, A. et al. (2015) [118]50124NT2
10Bergandi, L. et al. (2022) [116]60.11596T152Rezaie-Tavirani, M. et al. (2017) [117]5013T1
11Bergandi, L. et al. (2022) [116]60.11596T053Oh, I. et al. (2020) [119]501120T1
12Ledda, M. et al. (2018) [76]70.0125120NT154Morabito, C. et al. (2017) [84]501168NT0
13Ledda, M. et al. (2018) [76]70.0125120NT155Vianale, G. et al. (2008) [91]5014NT0
14Wang, M. et al. (2021) [79]7.830.548T156Vianale, G. et al. (2008) [91]50112NT0
15Wang, M. et al. (2021) [79]7.830.548T157Vianale, G. et al. (2008) [91]50124NT0
16Wang, M. et al. (2021) [79]7.830.548NT158Vianale, G. et al. (2008) [91]50148NT2
17Bergandi, L. et al. (2022) [116]811596T059Vianale, G. et al. (2008) [91]50172NT2
18Bergandi, L. et al. (2022) [116]811596T160Vianale, G. et al. (2008) [91]50196NT2
19Bergandi, L. et al. (2022) [116]1011548T161Wolf, F. et al. (2005) [120]50148T2
20Bergandi, L. et al. (2022) [116]1411548T162Wolf, F. et al. (2005) [120]50149NT2
21Ruiz Gómez, M.J. et al. (2000) [121]251.52.75T063Wolf, F. et al. (2005) [120]50150NT2
22Ruiz Gómez, M.J. et al. (2000) [121]251.52.75T164Kim, H. et al. (2013) [122]50148NT0
23Destefanis, M. et al. (2015) [123]500.045168T165Kim, H. et al. (2013) [122]501144NT1
24Destefanis, M. et al. (2015) [123]500.045168T166Kim, H. et al. (2013) [122]501288NT1
25Destefanis, M. et al. (2015) [123]500.045168T167Morabito, C. et al. (2017) [84]5010.5NT0
26Destefanis, M. et al. (2015) [123]500.045168T168Morabito, C. et al. (2017) [84]50124NT0
27Morabito, C. et al. (2017) [84]500.1168NT069Morabito, C. et al. (2017) [84]50148NT0
28Morabito, C. et al. (2010) [92]500.10.5T070Morabito, C. et al. (2017) [84]50172NT2
29Morabito, C. et al. (2010) [92]500.124T071Morabito, C. et al. (2017) [84]50196NT0
30Morabito, C. et al. (2010) [92]500.148T072Morabito, C. et al. (2017) [84]501120NT0
31Morabito, C. et al. (2010) [92]500.172T273Falone, S. et al. (2007) [94]50124T0
32Morabito, C. et al. (2010) [92]500.196T074Falone, S. et al. (2007) [94]50148T0
33Morabito, C. et al. (2010) [92]500.1120T075Falone, S. et al. (2007) [94]50172T0
34Morabito, C. et al. (2010) [92]500.1144T076Falone, S. et al. (2007) [94]50196T0
35Morabito, C. et al. (2010) [92]500.1168T077Kim, S. et al. (2017) [124]600.810NT0
36Morabito, C. et al. (2010) [92]500.1192T078Kim, S. et al. (2017) [124]600.820NT0
37Srdjenovic, B. et al. (2014) [125]500.13T279Huang, C. et al. (2014) [126]601.524NT0
38Srdjenovic, B. et al. (2014) [125]500.124T280Huang, C. et al. (2014) [126]601.548NT0
39Srdjenovic, B. et al. (2014) [125]500.148T281Huang, C. et al. (2014) [126]601.572NT0
40Qiu, L. et al. (2018) [127]500.41NT282Huang, C. et al. (2014) [126]601.596NT0
41Chen, L. et al. (2020) [128]500.41T283Huang, C. et al. (2014) [126]601.5120NT0
42Nezamtaheri, M. et al. (2022) [74]0.0112T184Huang, C. et al. (2014) [126]601.5144NT1
Table 4. A table containing the individual experiments of the articles selected according to the inclusion criteria for the analysis of the apoptosis results in continuous exposure mode. Results: non-significant (0); decrease (1); increase (2). Increasing order by frequency.
Table 4. A table containing the individual experiments of the articles selected according to the inclusion criteria for the analysis of the apoptosis results in continuous exposure mode. Results: non-significant (0); decrease (1); increase (2). Increasing order by frequency.
IDAuthorsFrequency (Hz)Intensity (mT)Exposure time (h)Cell Type (T/NT)ResultsIDAuthorsFrequency (Hz)Intensity (mT)Exposure Time (h)Cell Type (T/NT)Results
1Nezamtaheri, M. et al. (2022) [74]0.0112T235Ledda, M. et al. (2018) [76]1012T0
2Nezamtaheri, M. et al. (2022) [74]0.0112NT236Ledda, M. et al. (2018) [76]1012NT0
3Nezamtaheri, M. et al. (2022) [74]0.0112T037Ledda, M. et al. (2018) [76]1012T0
4Nezamtaheri, M. et al. (2022) [74]0.0112T038Ledda, M. et al. (2018) [76]1012T0
5Nezamtaheri, M. et al. (2022) [74]0.01124T039Ledda, M. et al. (2018) [76]10102T0
6Nezamtaheri, M. et al. (2022) [74]0.01124NT240Ledda, M. et al. (2018) [76]10102NT0
7Nezamtaheri, M. et al. (2022) [74]0.01124T041Ledda, M. et al. (2018) [76]10102T0
8Nezamtaheri, M. et al. (2022) [74]0.01148T042Ledda, M. et al. (2018) [76]10102T0
9Nezamtaheri, M. et al. (2022) [74]0.01148NT243Ledda, M. et al. (2018) [76]101002T0
10Nezamtaheri, M. et al. (2022) [74]0.01148T044Ledda, M. et al. (2018) [76]101002NT0
11Nezamtaheri, M. et al. (2022) [74]0.01172T045Ledda, M. et al. (2018) [76]101002T0
12Nezamtaheri, M. et al. (2022) [74]0.01172NT046Ledda, M. et al. (2018) [76]101002T0
13Nezamtaheri, M. et al. (2022) [74]0.01172T047Ruiz Gómez, M.J. et al. (2001) [121]251.52.75T0
14Nezamtaheri, M. et al. (2022) [74]0.011120NT248Ruiz Gómez, M.J. et al. (2001) [121]251.52.75T0
15Nezamtaheri, M. et al. (2022) [74]0.011002T049Falone, S. et al. (2007) [94]50124T0
16Nezamtaheri, M. et al. (2022) [74]0.011002NT050Falone, S. et al. (2007) [94]50148T0
17Nezamtaheri, M. et al. (2022) [74]0.011002T051Falone, S. et al. (2007) [94]50172T0
18Nezamtaheri, M. et al. (2022) [74]0.011002T052Falone, S. et al. (2007) [94]50196T0
19Nezamtaheri, M. et al. (2022) [74]0.112T053Garip, A. et al. (2010) [90]5013T1
20Nezamtaheri, M. et al. (2022) [74]0.112NT054Ding, Z. et al. (2017) [129]502.316NT0
21Nezamtaheri, M. et al. (2022) [74]0.1102T055Ding, Z. et al. (2017) [129]502.316NT2
22Nezamtaheri, M. et al. (2022) [74]0.11002T056Yin, C. et al. (2016) [80]50890NT2
23Nezamtaheri, M. et al. (2022) [74]112T057Ramazi, S. et al. (2023) [130]502024T0
24Nezamtaheri, M. et al. (2022) [74]1102T058Akbarnejad, Z. et al. (2017) [95]1001072T0
25Nezamtaheri, M. et al. (2022) [74]11002T059Akbarnejad, Z. et al. (2017) [95]1001072T0
26Nezamtaheri, M. et al. (2022) [74]11002NT060Akbarnejad, Z. et al. (2017) [95]1001072T0
27Nezamtaheri, M. et al. (2022) [74]11002T261Akbarnejad, Z. et al. (2017) [95]1001096T0
28Nezamtaheri, M. et al. (2022) [74]11002T062Akbarnejad, Z. et al. (2017) [95]1001096T0
29Nezamtaheri, M. et al. (2022) [74]110024T063Akbarnejad, Z. et al. (2017) [95]1001096T0
30Nezamtaheri, M. et al. (2022) [74]110048T064Akbarnejad, Z. et al. (2017) [95]10010120T0
31Nezamtaheri, M. et al. (2022) [74]110072T065Akbarnejad, Z. et al. (2017) [95]10010120T0
32Nezamtaheri, M. et al. (2022) [74]1100120T266Akbarnejad, Z. et al. (2017) [95]10010144T2
33Ledda, M. et al. (2018) [76]70.0125120NT067Akbarnejad, Z. et al. (2017) [95]10010144T2
34Ledda, M. et al. (2018) [76]70.0125120NT2
Table 5. A table containing the individual experiments of the articles selected according to the inclusion criteria for the analysis of the oxidative stress results in continuous exposure mode. Results: non-significant (0); decrease (1); increase (2). Increasing order by frequency.
Table 5. A table containing the individual experiments of the articles selected according to the inclusion criteria for the analysis of the oxidative stress results in continuous exposure mode. Results: non-significant (0); decrease (1); increase (2). Increasing order by frequency.
IDAuthorsFrequency (Hz)Intensity (mT)Exposure Time (h)Cell Type (T/NT)ResultsIDAuthorsFrequency (Hz)Intensity (mT)Exposure Time (h)Cell Type (T/NT)Results
1Nezamtaheri, M. et al. (2022) [74]0.011120T233Iorio, R. et al. (2010) [131]5051NT0
2Nezamtaheri, M. et al. (2022) [74]0.011120NT234Iorio, R. et al. (2010) [131]5052NT2
3Nezamtaheri, M. et al. (2022) [74]0.011120T035Iorio, R. et al. (2010) [131]5053NT2
4Nezamtaheri, M. et al. (2022) [74]10.1120T236Patruno, A. et al. (2010) [132]5013NT2
5Srdjenovic, B. et al. (2014) [125]500.043T037Patruno, A. et al. (2010) [132]50118NT2
6Srdjenovic, B. et al. (2014) [125]500.0424T038Wolf, F. et al. (2005) [120]5013NT0
7Destefanis, M. et al. (2015) [123]500.04572T239Wolf, F. et al. (2005) [120]50124NT0
8Destefanis, M. et al. (2015) [123]500.04572T240Morabito, C. et al. (2010) [92]5010.5T2
9Destefanis, M. et al. (2015) [123]500.045168T241Reale, M. et al. (2014) [93]5013T2
10Destefanis, M. et al. (2015) [123]500.045168T242Reale, M. et al. (2014) [93]5016T2
11Calcabrini, C. et al. (2017) [83]500.051NT143Reale, M. et al. (2014) [93]50124T2
12Calcabrini, C. et al. (2017) [83]500.052NT244Frahm, J. et al. (2006) [133]5010.75NT2
13Calcabrini, C. et al. (2017) [83]500.054NT045Falone, S. et al. (2007) [94]50124T0
14Frahm, J. et al. (2006) [133]500.050.75NT246Falone, S. et al. (2007) [94]50148T0
15Morabito, C. et al. (2010) [92]500.10.5T047Falone, S. et al. (2007) [94]50172T0
16Frahm, J. et al. (2006) [133]500.10.75NT248Falone, S. et al. (2007) [94]50196T0
17Srdjenovic, B. et al. (2014) [125]500.13T049Yin, C. et al. (2016) [80]5081.5NT2
18Srdjenovic, B. et al. (2014) [125]500.124NT050Ramazi, S. et al. (2023) [130]502024T2
19Calcabrini, C. et al. (2017) [83]500.11NT251Kim, S. et al. (2017) [134]600.820NT2
20Calcabrini, C. et al. (2017) [83]500.12NT252Falone, S. et al. (2007) [94]6060.5T0
21Calcabrini, C. et al. (2017) [83]500.14NT053Song, K. et al. (2018) [89]60672T1
22Calcabrini, C. et al. (2017) [83]500.151NT054Song, K. et al. (2018) [89]60672NT1
23Calcabrini, C. et al. (2016) [83]500.21NT055Song, K. et al. (2018) [89]606168T1
24Frahm, J. et al. (2006) [133]500.50.75NT256Song, K. et al. (2018) [89]606168NT1
25Patruno, A. et al. (2020) [135]5011T257Akbarnejad, Z. et al. (2017) [95]1001072T0
26Patruno, A. et al. (2020) [135]5016T158Akbarnejad, Z. et al. (2017) [95]1001072T0
27Patruno, A. et al. (2020) [135]50124T259Akbarnejad, Z. et al. (2017) [95]1001096T2
28Park, J. et al. (2013) [88]5011.5NT260Akbarnejad, Z. et al. (2017) [95]1001096T2
29Park, J. et al. (2013) [88]50196NT261Akbarnejad, Z. et al. (2017) [95]10010120T2
30Garip, A. et al. (2010) [90]5013T262Akbarnejad, Z. et al. (2017) [95]10010120T2
31Buldak, R. et al. (2012) [136]5010.66T063Akbarnejad, Z. et al. (2017) [95]10010144T2
32Ayse, I. et al. (2010) [109]5051T264Akbarnejad, Z. et al. (2017) [95]10010144T2
Table 6. A table containing the individual experiments of the articles selected according to the inclusion criteria for the analysis of the cell cycle results in continuous exposure mode. Results: non-significant (0); significant (1). Increasing order by frequency.
Table 6. A table containing the individual experiments of the articles selected according to the inclusion criteria for the analysis of the cell cycle results in continuous exposure mode. Results: non-significant (0); significant (1). Increasing order by frequency.
IDAuthorsFrequency (Hz)Intensity (mT)Exposure Time (h)Cell Type (T/NT)ResultsIDAuthorsFrequency (Hz)Intensity (mT)Exposure Time (h)Cell Type (T/NT)Results
1Nezamtaheri, M. et al. (2022) [74]0.0112T127Falone, S. et al. (2007) [94]50148T0
2Nezamtaheri, M. et al. (2022) [74]0.011120T128Falone, S. et al. (2007) [94]50172T0
3Nezamtaheri, M. et al. (2022) [74]0.011120NT129Falone, S. et al. (2007) [94]50196T0
4Nezamtaheri, M. et al. (2022) [74]0.011120T130Song, K. et al. (2018) [89]60624T0
5Nezamtaheri, M. et al. (2022) [74]0.011120T131Song, K. et al. (2018) [89]60624NT0
6Nezamtaheri, M. et al. (2022) [74]1100120T132Song, K. et al. (2018) [89]60648T0
7Nezamtaheri, M. et al. (2022) [74]1100120T133Song, K. et al. (2018) [89]60648NT0
8Ruiz Gómez, M.J. et al. (2001) [121]251.52.75T034Song, K. et al. (2018) [89]60672T0
9Ruiz Gómez, M.J. et al. (2001) [121]251.62.75T035Song, K. et al. (2018) [89]60672NT0
10Patruno, A. et al. (2015) [118]5011NT136Song, K. et al. (2018) [89]606168T0
11Patruno, A. et al. (2015) [118]50124NT137Song, K. et al. (2018) [89]606168NT0
12Oh, I. Et al. (2020) [119]501120T138Cho, S. et al. (2014) [81]600.824NT0
13Oh, I. Et al. (2020) [119]501120T139Huang, C. et al. (2014) [126]601.524NT0
14Yin, C. et al. (2016) [80]5081.5NT140Huang, C. et al. (2014) [126]601.524NT0
15Wolf, F. et al. (2005) [120]50112NT141Huang, C. et al. (2014) [126]601.548NT0
16Wolf, F. et al. (2005) [120]50124NT042Huang, C. et al. (2014) [126]601.572NT0
17Wolf, F. et al. (2005) [120]50124NT143Huang, C. et al. (2014) [126]601.596NT0
18Wolf, F. et al. (2005) [120]50172NT044Huang, C. et al. (2014) [126]601.5120NT0
19Huang, C. et al. (2014) [126]501.524NT045Huang, C. et al. (2014) [126]601.5144NT0
20Huang, C. et al. (2014) [126]501.548NT046Huang, C. et al. (2014) [137]601.524NT0
21Huang, C. et al. (2014) [126]501.572NT047Huang, C. et al. (2014) [137]601.548NT0
22Huang, C. et al. (2014) [126]501.596NT048Huang, C. et al. (2014) [137]601.572NT0
23Huang, C. et al. (2014) [126]501.5120NT049Huang, C. et al. (2014) [137]601.596NT0
24Huang, C. et al. (2014) [126]501.5144NT050Huang, C. et al. (2014) [137]601.5120NT0
25Ma, Q. et al. (2014) (42)50272NT051Huang, C. et al. (2014) [137]601.5144NT1
26Falone, S. et al. (2007) (46)50124T052Mihai, C. et al. (2014) [138]1005.60.75NT1
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

López de Mingo, I.; Rivera González, M.-X.; Maestú Unturbe, C. The Cellular Response Is Determined by a Combination of Different ELF-EMF Exposure Parameters: A Scope Review. Int. J. Mol. Sci. 2024, 25, 5074. https://doi.org/10.3390/ijms25105074

AMA Style

López de Mingo I, Rivera González M-X, Maestú Unturbe C. The Cellular Response Is Determined by a Combination of Different ELF-EMF Exposure Parameters: A Scope Review. International Journal of Molecular Sciences. 2024; 25(10):5074. https://doi.org/10.3390/ijms25105074

Chicago/Turabian Style

López de Mingo, Isabel, Marco-Xavier Rivera González, and Ceferino Maestú Unturbe. 2024. "The Cellular Response Is Determined by a Combination of Different ELF-EMF Exposure Parameters: A Scope Review" International Journal of Molecular Sciences 25, no. 10: 5074. https://doi.org/10.3390/ijms25105074

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop